Urtica dioica-Derived Phytochemicals for Pharmacological and Therapeutic Applications

Abstract

Urtica dioica belongs to the Urticaceae family and is found in many countries around the world. This plant contains a broad range of phytochemicals, such as phenolic compounds, sterols, fatty acids, alkaloids, terpenoids, flavonoids, and lignans, that have been widely reported for their excellent pharmacological activities, including antiviral, antimicrobial, antihelmintic, anticancer, nephroprotective, hepatoprotective, cardioprotective, antiarthritis, antidiabetic, antiendometriosis, antioxidant, anti-inflammatory, and antiaging effects. In this regard, this review highlights fresh insight into the medicinal use, chemical composition, pharmacological properties, and safety profile of U. dioica to guide future works to thoroughly estimate their clinical value.

This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

1. Introduction

Genus Urtica, commonly known as “nettle,” is a medicinal plant belonging to the family Urticaceae with multiple health benefits that have been used medicinally since at least the times of Ancient Greece [1]. Several Urtica species have been widely used to treat rheumatism and sciatica, asthma, coughs, dandruff, diabetes, diarrhea, eczema, fever, gout, hemorrhoids, nose bleeds, scurvy, snake bites, and tuberculosis [2]. Moreover, Urtica species have been used most commonly as a diuretic and for treating gout, anemia, and prostate hypertrophy, with several studies progressively reporting their traditional medicinal use by local people [2–11].

These studies originated mostly from African, European, Asian, and Oceanian countries, such as Algeria, Argentina, Australia, Bolivia, Bhutan, Brazil, Bolivia, Belarus, Bolivia, Canada, Chile, China, Colombia, Cyprus, Costa Rica, Cuba, Ecuador, Egypt, France, Guatemala, India, Italy, Israel, Japan, Korea, Mexico, Nepal, New Zealand, Netherlands, North America, Palestine, Paraguay, Peru, Russia, Sikkim, Sweden, Spain, Taiwan, Turkey, Tunisia, United States, Uruguay, Ukraine, and Vietnam [2–11].

Data obtained from these studies mostly underlined that Urtica species exert excellent antirheumatoid arthritis, antigout, anti-inflammatory, immunomodulatory, and antioxidant activities, all of which contribute to the protection of joints. In addition, it has been revealed to be extremely useful for the treatment of microbial and parasitic infections, cancer, jaundice, stomach diseases, snakebites, diabetes, liver and kidney problems, wounds, diuretic, libido, pulmonary diseases, hypotensive, blood purification, urticaria, allergic rhinitis, prostate disorders, hemorrhoids, and galactagogue and as a depurative. Apart from this, these species have also been reported to be used for exorcism, postcalving care, sprains, bones fracture, hematuria, neck sore, and yolk sore [2, 12–26].

Despite the scientific advances that have allowed us to understand the crucial contribution of the active molecules present in this plant for their biological and therapeutic potentialities, the relevance of this knowledge goes beyond chemical features, as it is necessary to understand that due to the increased daily living standards of rural populations, decisions regarding the sustainable use of plant resources have been even more underlined [27, 28]. In this sense, this review aims to provide an overview of the botanical features, chemical composition, and biological effects of Urtica species towards well-being promotion and disease prevention.

2. Botanical Features and Geographical Location

Urtica species is a nitrophilous plant that can grow up to 1-2 m in height depending on edaphic conditions. Despite growing well in areas with high water availability [29–31], the plant can spread widely with its stoloniferous rhizomes [32].

Leaves are simple, dark green, stipulate, opposite, serrated, oblong, or ovate with cordate base [33, 34]. Both leaves surfaces are coated with stinging hairs; except in the European variety (Urtica galeopsifolia), the stinging hairs are absent [35]. Stem is green, erect, hollow to solid, fibrous and tough, indumentum of many stinging hairs and trichomes.

Flowers are small, reddish-brown to greenish-white in colour, mostly dioecious occurring as racemes in the axial of the upper leaves; staminate flowers with 4-5 long tepals, stamens 4, exserted, filaments flat; pistillate flowers with 4 short tepals, sparsely pubescent, esetulose, ovary superior, ovoid, 1-celled [1, 32, 34].

Urtica species present a subcosmopolitan distribution, being found around the globe, except in Antarctica and some tropical regions [36, 37]. The plant is commonly found as a weed, mainly in moist and shady places and often in anthropogenic habitats. The genus comprises 46 species, being the most important Urtica dioica (stinging nettle) and Urtica urens (small nettle), which are native to Europe, Africa, Asia, North America, and naturalized in other temperate parts of the world (Table 1) [2, 5].

Table 1

Geographical distribution, traditional uses, and pharmacology of Urtica species.

No.	Species	Geographical distribution	Traditional uses	Pharmacological activities
1	Urtica andicola Wedd.	Turkey	Skin rashes, arthritis, fungal infections	—
2	Urtica angustifolia Fisch. ex Hornem.	China, Japan, Korea, Mongolia, Siberia	None known	Antifatigue
3	Urtica ardens Link	Bhutan, India, Nepal, Sikkim	Exorcism, jaundice, postcalving care, sprains, bones fracture, hematuria, neck sore, yolk sore	—
4	Urtica aspera Petrie	New Zealand	Stomach diseases, snakebites, inflammation, rheumatoid arthritis, hyperplasia, fungal infections	—
5	Urtica atrichocaulis (Hand.-Mazz.) C.J. Chen	China, Japan, Korea, Himalayas, Pakistan	Rheumatoid arthritis, inflammatory, antioxidant, immune-modulatory	—
6	Urtica atrovirens Req. ex Loisel	France, Italy, Spain	Antihyperglycemic, antioxidant, hepatic protective, antiviral, arthritis	—
7	Urtica australis Hook.f.	New Zealand	Skin diseases, diabetes, eczema, fungal infections, arthritis	—
8	Urtica ballotifolia Wedd.	Colombia, Ecuador	—	—
9	Urtica berteroana Phil	Chile, Bolivia, Argentina, Colombia	—	—
10	Urtica buchtienii Ross	Chile, Argentina	—	—
11	Urtica cannabina L.	Russia, Sweden, Netherlands, China, Western Asia from Siberia to Iran	—	Anti-inflammatory
12	Urtica chamaedryoides Pursh	United States, Mexico	—	—
13	Urtica circularis Sorarú	Brazil, Argentina, Paraguay, Uruguay	—	Antioxidant, anti-inflammatory
14	Urtica deltoidea Sw.	New Zealand	Arthritis, inflammation, antiulcer, anticancer, antimicrobial activities	—
15	Urtica dentate Hand.-Mazz	North America	Kidney problems, rheumatoid arthritis, kidney calculi	Antiarthritis, antiurolithiatic
16	Urtica dioica L.	United States, New Zealand, Turkey, Europe, Asia, North America	Injuries to reduce swelling, diuretic, flu, diabetes disease, losing weight, cold, cancers, anemic conditions, libido, induce menstruation, stomach- ache, renal and pulmonary diseases	Antiviral, antimicrobial, antioxidant, anti-inflammatory antiaging, cytotoxic/anticancer Effect on benign prostatic hyperplasia, antidiabetic, antiendometriosis, nephroprotective
17	Urtica echinata Benth	Bolivia, Peru, Argentina, Ecuador	—	—
18	Urtica ferox Blanco	New Zealand, Australia	Skin problems, hyperglycemic, antiviral, diuretic, hypotensive, antiaggregate	—
19	Urtica fissa E. Pritz	China, Taiwan, Egypt, Vietnam	Rheumatoid arthritis	—
20	Urtica flabellata Kunth	Bolivia, Peru, Ecuador, Chile, Colombia, Turkey	Skin rashes, arthritis, fungal infections	—
21	Urtica galeopsifolia J. Jacq. ex Blume	Russia, Ukraine, Belarus	Renal ailments, asthma, anemia, blood purification	—
22	Urtica gracilenta Greene		Kidney diseases, diabetes, fungal infections	—
23	Urtica glomeruliflora Steud.	Chile		—
24	Urtica haussknechtii Boiss.	Turkey		—
25	Urtica hyperborea Jacq. exWedd.	Nepal, India, China	Skin rashes, arthritis, fungal infections	Antioxidant
26	Urtica incana Blume	Peru	Skin rashes, arthritis, fungal infections	—
27	Urtica kioviensis Rogow.	Europe, Israel, Russia	Arthritis, hepatic protective, antiviral	—
28	Urtica lalibertadensis Weigend	Peru	Skin rashes, arthritis, fungal infections	—
29	Urtica laetevirens Maxim.	China, Japan, Korea		Anticancer
30	Urtica leptophylla Kunth	Costa Rica, Colombia, Peru, Bolivia, Ecuador	Skin rashes, arthritis, fungal infections	—
31	Urtica lilloi (Hauman) Geltman	Argentina		—
32	Urtica longispica Killip	Ecuador, Peru, Colombia	Cough, eczema, gout, urticaria, allergic rhinitis, rheumatoid arthritis	—
33	Urtica macbridei Killip	Ecuador, Peru		—
34	Urtica magellanica Juss. ex Poir.	Chile, Peru, Bolivia, Argentina, Ecuador	Allergy, arthritis	—
35	Urtica mairei H. Lév.	China, India, Bhutan, Himalaya, Myanmar	Kidney pain. Its extract and paste kidney diseases, diabetes, fungal infections, inflammation, arthritis	Antiprotatic hyperplasia
36	Urtica masafuerae Phil.	Chile		—
37	Urtica massaica Mildbr.	Africa	Skin rashes, malaria, eczema, skin rashes, dermatitis, diuretic	—
38	Urtica membranacea Poir. ex Savigny	Israeli, Europe, Algeria	—	Antioxidant, anti-inflammatory
39	Urtica mexicana Liebm	Mexico, Guatemala	—	—
40	Urtica mollis Steud.	Peru, Chile, Argentina	—	—
41	Urtica morifolia Poir.	Europe	—	—
42	Urtica orizabae Liebm.	Mexico, United States, Cuba	—	—
43	Urtica parviflora Roxb.	Nepal, India, United States, Western China, Bhutan, Himalaya	Arthritis, tumor, astringent, diuretic, inflammatory	Nephroprotective, antidiabetic, antioxidant
44	Urtica pilulifera L.	Tunisia, Israel, Cyprus, Costa Rica, Turkey, Palestine	Skin and prostate disorders, rheumatoid arthritis, diabetes, skin treatment, inflammation, arthritis, internal bleeding, anemia, excessive menstruation, hemorrhoids, rheumatism, hay fever, kidney problems, pain, skin problems, abdominal pain, internal diseases, antiasthmatic, antitumor, astringent, diuretic, galactagogue, depurative, antihyperglycemic, antidandruff	Antidiabetic
45	Urtica platyphylla Wedd.	Japan, Russia	—	—
46	Urtica praetermissa V.W. Steinm.	Mexico	—	—
47	Urtica pubescens Ledeb.	Mexico	—	—
48	Urtica rupestris Guss.	Italy	—	—
49	Urtica sondenii (Simmons) Avrorin ex Geltman	Canada	—	—
50	Urtica spiralis Blume	Mexico	—	—
51	Urtica stachyoidesWebb & Benth.	Spain, Mexico	—	—
52	Urtica taiwaniana S.S. Ying	Taiwan	—	—
53	Urtica thunbergiana Siebold & Zucc.	Japan, Korea, China	—	Antiaging
54	Urtica triangularis Hand.-Mazz.	China	—	—
55	Urtica trichantha (Wedd.) Acevedo & Navas	Chile, Bolivia, Peru, Japan, China	—	—
56	Urtica urens L.	Unite States, Mexico, Europe, Israel, New Zealand	Blood depurative, antihypoglycemic, antioxidant, hepatic protective, antiviral, diuretic, hypotensive, antiaggregate, kidney problems	Antioxidant, anti-inflammatory

The widely distributed weedy species, U. dioica, is considered an ecological keystone species and, thus, it is significantly important for the biodiversity in the ecosystem [38–42]. Island endemics are very common within this genus and the species include U. dioica subsp. cypria on Cyprus island, Urtica atrovirens on Corsica and Sardinia, Urtica rupestris on Sicily, Urtica stachyoides on the Canary Islands, Urtica portosanctana on Madeira, Urtica bianorii on Mallorca, Urtica domingensis on Hispaniola, Urtica glomerulaeflora on Juan Fernández Islands, Urtica grandidentata on Indonesia, Urtica taiwaniana on Taiwan, Urtica papuana on Papua New Guinea, and Urtica perconfusa on New Zealand. This indicates that island colonization within the genus is a unique feature amongst the flowering plants [3, 4].

3. Phytoconstituents

Phytochemicals are plant metabolites produced in response to any infectious attack or as a byproduct of any metabolic pathway, despite exerting beneficial effects in many ways [43, 44]. The active chemical part of nettle includes nearly fifty compounds of the lipophilic and hydrophilic fractions and whose chemical structure is known. Globally, few Urtica species have been screened for their phytochemical composition, with those available so far reporting the presence of sterols, triterpenes, coumarins, phenols, lignans, ceramides, and fatty acids, amongst other minor compounds, all with a distribution varying in the various organs of the plant (Tables 2–11).

Table 2

Lignans extracted from Urtica.

Sr. no.	Compound name	Structural
1.	Cycloolivil; 9′-O-b-d-Glucopyranoside
2.	4-[Bis(3, 4-dihydroxyphenyl) methyl]dihydro-3-(hydroxymethyl)-2(3H)-furanone; (8R${}^{\ast }$, 8′R${}^{\ast }$)-form,3′, 4-Di-Me ether, 7-O-b-D-glucopyranoside
3.	4-[Bis(3, 4-dihydroxyphenyl) methyl]dihydro-3-(hydroxymethyl)-2(3H)-furanone; (8R${}^{\ast }$, 8′R${}^{\ast }$)-form,3′, 4-Di-Me ether, 4′-O-b-D-glucopyranoside
4.	4-[Bis(3, 4-dihydroxyphenyl) methyl]dihydro-3-(hydroxymethyl)-2(3H)-furanone; (8R${}^{\ast }$, 8′R${}^{\ast }$)-form,3′, 4-Di-Me ether
5.	Neoolivil
6.	3, 3′, 4, 4′, 8′, 9-Hexahydroxy-7, 9′-epoxylignan; (7S,8R, 8′S)-form, 3, 3′-Di-Me ether, 9-O-β-D-glucopyranoside
7.	3, 3′, 4, 4′, 8′, 9-Hexahydroxy-7, 9′-epoxylignan; (7S,8R,8′S)-form, 3, 3′, 4-Tri-Me ether, 8′-Ac
8.	3, 3′, 4, 4′, 8′, 9-Hexahydroxy-7, 9′-epoxylignan; (7S,8R,8′S)-form, 3, 3′, 4-Tri-Me ether, 8′-Ac, 4′-O-[aarabinopyranosyl-(1 ⟶ 6)-bd-glucopyranoside]
9.	Neoolivil; 9-Ac, 4-O-b-D-glucopyranoside
10.	Neoolivil; 4-O-b-D-glucopyranoside
11.	Neoolivil; 9, 9′-Di-Ac, 4-O-b-D-glucopyranoside
12.	Pinoresinol; (+)-form, 4-O-[a-L-rhamnopyranosyl-(1 ⟶ 2)-b-d-glucopyranoside]
13.	Secoisolariciresinol
14.	Isolariciresinol
15.	Urticene; (−)-form
16.	Neoolivil; 9-O-b-d-Glucopyranoside
17.	Dehydrodiconiferyl alcohol
18.	Olivil
19.	3,4-Divanillyltetrahydrofuran

Table 3

Sterols extracted from Urtica.

Sr. no.	Compound name	Structural formula
1.	Stigmastane-3, 6-diol; (3β, 24R)-form, O-[b-d-Glucopyranosyl-(1 ⟶ 4)-al-arabinopyranoside]
2.	Stigmastane-3, 6-diol; (3b, 7a, 24R)-form, 3-O-b-d-Glucopyranoside
3.	Stigmastane-3, 6-diol; (3b, a6a, 24R)-form
4.	Daucosterol
5.	Ethyl iso-allocholate
6.	Cholesterol

Table 4

Fatty acids isolated from genus Urtica.

Sr.	Name	Structural formula
1	Palmitic acid
2	Erucic acid
3	Linolenic acid
4	Pentadecanoic acid

Table 5

Flavonoids isolated from genus Urtica.

Sr.	Name
1.	2′, 4′, 5, 7, 8-Pentahy-droxyflavone; 7, 8-Di-Me ether
2.	Luteolin 7-O-neohes-peridoside
3.	Quercetin
4.	Kaempferol
5.	Nicotiflorin
6.	Gossypetin
7.	Luteolin 7-O-b-d-Glucopyranoside
8.	Afzelin
9.	Isovitexin
10.	Astragalin

Table 6

Phenols extracted from Urtica spp.

Sr. no.	Compound name	Structural formula
1.	p-Coumaric acid
2.	Vanillic acid
3.	4-Methoxybenzoic acid
4.	Caffeoylmalic acid
5.	Ferulic Acid
6.	Chlorogenic acid
7.	Salicylic acid
8.	Protocatechuic aldehyde
9.	Caffeic acid

Table 7

Alcohols isolated from genus Urtica.

Sr.	Name	Chemical structure
1.	N-Tetracosanoylphytosphingosine
2.	Erythritol
3.	1, 2, 3-Butanetriol
4.	14-Octacosanol

Table 8

Alkaloids isolated from genus Urtica.

Name	Chemical structure
Benzylisoquinoline
Chlorophyll A
Chlorophyll B

Table 9

Benzopyranoids isolated from genus Urtica.

Sr.	Name	Chemical structure
1.	6, 6′, 7, 7′-Tetrahy-droxy-[8, 8′-bi-2H-1-benzopyran]-2, 2′-dione; Tetra-Me ether
2.	7, 7′-dimethoxy-6, 6′-biscoumarin
3.	Scopolin
4.	6, 6′, 7, 7′-Tetrahydroxy-8,8′-bicoumarin; 6, 6′-Di-Me ether
5.	Scoparone
6.	Scopoletin

Table 10

Other compounds isolated from genus Urtica.

Sr.	Name	Chemical structure
1.	Tartaric acid
2.	Bis(5-formylfurfu-ryl) ether
3.	Dotriacotane
4.	2, 3-Dihydrobenzo-furan
5.	Formic acid
6.	Oxime- methoxy-phenyl
7.	1-Methoxy-4, 4a, 5, 6, 7, 8-hexahydro-2 (3H)-naphthalenone
8.	Silane, triethyl (2-phenylethoxy)
9.	N, N-Dimethyldo-decylamine
10.	Naphthalene

Table 11

Terpenoids isolated from genus Urtica.

Sr.	Name	Structural name
1.	3′-Hydroxyacetophenone
2.	4,7-Megastigma-diene-3, 9-diol; (3S,6R,7E,9R)-form, 3-Ketone, 9-O-[b-D-glucopyranosyl-(1 ⟶ 2)-b-d-glucopyranoside]
3.	1-(3, 4-Dihydroxyphe-nyl)-1, 2-propanediol; 3′-Me ether
4.	(9Z,11E)-1, 3-hy-droxy-9, 11-octadeca-dienoic acid
5.	Hexahydrofarnesyl acetone
6.	Geranyl acetone
7.	(E)-Anethole
8.	p-Hydroxybenzalde-hyde
9.	b-Ionone

Beta-sitosterol, transferulic acid, dotriacontane, erucic acid, ursolic acid, scopoletin, rutin, quercetin, and phydroxylbenzalcohol are some of the constituents found in Urtica species that may be applied for preventive or therapeutic purposes in communicable and noncommunicable diseases [16, 45–59]. The liquid contained in the hairs of a nettle causes it to sting, being composed of formic acid and leukotrienes in modest amounts, 1% acetylcholine, 1 in 500 to 1 in 2000 histamine, and 5-hydroxy-tryptamine (serotonin).

Essential ketones (38.5%), esters (14.7%), free alcohols (2%), nitrogenous compounds, phenols, aldehydes, p-sitosterol, formic acid and acetic acid, chlorophyll and phytol, vitamins, and carotenoids are also found in the aerial sections. Many organic acids were also identified in the aerial parts, including caffeic, ferulic, caffeylmalic, chlorogenic, and sinapic acids, according to chromatographic examination.

Flavonoids: isorhamnetol 3-O-glucoside, quercetol 3-O-glucoside, kaempferol 3-O-glucoside, isorhamnetol 3-O-rutinoside, and quercetol 3-O-rutinoside were extracted and identified in flowers, in addition to p-sitosterol, p-sitosterol glucoside, and scopoletol, which are found in all sections of the plant. The roots contained many molecules belonging to different chemical families, including polysaccharides: glycans, glucogalacturonans, arabinogalactan acid, fatty acid: (10E, 12Z)-9-hydroxy-10, 12-octadecadienoic acid, lectins, ceramides, terpenes diols, and terpenes diols glucosides [60].

Amongst Urtica species, Urtica pilulifera and U. dioica essential oil compositions have been investigated and consist mainly of hexahydrofarnesyl acetone, 1,8-cineole, α -ionone, β-ionone, farnesylacetone, methylbenzene, (−)-limonene, 3-carene, (+)-limonene, gamma-terpinene, vanillin, butyl acetate, 1, 2-benzenedicarboxylic acid, and 7-acetyl-6-ethyl-1, 1, 4, 4-tetramethyltetralin (Table 12) [61, 62]. Overall, considerably less attention has been paid to the phytochemistry of bioactive compounds in these plants.

Table 12

Chemical composition of essential oil extracted of Urtica pilulifera and Urtica diorca.

NO	Compound	Urtica pilulifera (RT)	Urtica diorca (RI)	%
1	1-(4-Isopropylphenyl)-2-methylpropyl acetate	30.5829	—	2.062
2	1-(4′-pentenyl)-1, 2-epoxycyclopentane	24.2355	—	0.1271
3	1, 2-Benzenedicarboxylic acid	32.0424	—	13.5056
4	1, 4-Diazepine	27.0528	—	0.3009
5	1,8-Cineole	13.686	—	8.2085
6	1-Penten-3-one	27.5551	—	0.3782
7	2-(1-Pentenyl)furan	—	1056	0.29
8	2, 2, 6-Trimethylcyclohexanone	—	1035	0.28
9	2, 4, 6-Trimethyl-5H-1, 3, 5-dithiazine	—	1199	0.30
10	2-Methoxy-4-vinylphenol	12.3214	—	0.1087
11	2-Pentylfuran	—	991	0.84
12	2-Propenoic acid	5.302	—	2.2418
13	3, 5-Dimethyl-1, 2, 4-trithiolane	—	1134	0.30
14	3-Carene	15.8651	—	3.7624
15	3-Octanone	—	988	0.28
16	5, 6-Dihydro-4-pentyl-2, 6-dimethyl-4H-1, 3, 5-dithiazine	—	1588	0.57
17	5, 6-Dihydro-4-pentyl-2, 6-dimethyl-4H-1, 3, 5-dithiazine	—	1588	0.57
18	7-Acetyl-6-ethyl-1, 1, 4,4-tetramethyltetralin	32.5855	—	19.618
19	.alpha-Cetone	26.6658	—	0.9039
20	Anozol	29.1437	—	0.1346
21	Apoatropine	—	2093	0.82
22	Apoatropine	—	2093	0.82
23	Benzaldehyde	11.371	—	0.1391
24	Benzaldehyde	—	964	0.29
25	Benzofuranone	27.9014	—	0.1183
26	Benzoic acid	30.7118	—	0.873
27	Bicyclo[10.1.0]trideca-4, 8-diene-13-carboxamide	25.2741	—	0.1325
28	Bisabolene	—	1506	0.39
29	Bisomel	32.28	—	3.7872
30	Borneol	—	1171	0.31
31	Bornyl acetate	—	1283	2.14
32	Butyl acetate	6.7208	—	3.2399
33	Cadinene	—	1510	1.57
34	Cadinene	—	1516	2.37
35	Camphor	—	1145	0.27
36	Carvacrol	—	1299	0.30
37	Carvone	20.9362	—	0.1721
38	Citronellyl	19.7143	—	0.1388
39	Copaene-8-ol	—	1579	3.28
40	Decan-2-one	—	1192	0.28
41	Decanal	—	1206	0.29
42	Diethoxylated tridecyl alcohol	30.9494	—	0.1828
43	Ethylhexyl benzoate	31.187	—	0.3837
44	Farnesol	—	1715	1.88
45	Farnesol	—	1715	1.88
46	Farnesylacetone	—	1908	1.26
47	Farnesylacetone	—	1908	1.26
48	Furan-3-aldehyde	7.325	—	0.1458
49	Geranyl acetone	25.953	—	0.3483
50	Geranyl acetone	—	1448	2.22
51	Geranyl acetone	—	1448	2.22
52	Hexahydrofarnesylacetone	—	1844	31.20
53	Hexahydrofarnesylacetone	—	1844	31.20
54	Hexatriacontane	6.7208	—	11.5631
55	Humulene	—	1453	0.75
56	-Ionon β	26.822	—	0.1714
57	Ionone	—	1421	4.04
58	Ionone	—	1479	11.86
59	Isopropyl dodecanoate	—	1627	5.27
60	Isopropyl dodecanoate	—	1627	5.27
61	Lilyal	27.7113	—	1.8666
62	Limonene (−)-	13.5638	—	1.2463
63	Limonene (+)-	23.3733	—	6.7658
64	Menthol	—	1178	0.29
65	Methyl dihydrojasmonate	30.3181	—	0.8451
66	Methyl palmitate	—	1925	0.28
67	Methyl palmitate	—	1925	0.28
68	Methylbenzene	5.302	—	1.6415
69	Neophytadiene	32.3751	—	5.2683
70	n-Nonanal	15.9873	—	0.3288
71	n-Octanal	—	1004	0.30
72	Nonanal	—	1105	0.59
73	Ocimene	20.59	—	0.6869
74	Octanal	31.6555	—	2.0563
75	Octyl heptafluorobutyrate	17.9696	—	0.1347
76	p-Guaiacol	15.5392	—	0.1521
77	Phytol	—	2110	11.20
78	Phytol	—	2110	11.20
79	Safranal	—	1196	0.33
80	β-Selinene	—	1485	0.78
81	Terpinene	14.5413	—	0.1705
82	Thymol	—	1292	0.60
83	Trans-2,3-dimethylbicyclo[2.2.2]octane	22.4161	—	0.3454
84	Vanillin	21.812	—	1.7906
85	Vetivenene	—	1532	0.49
86	Vinyl	31.0445	—	0.3754
87	Xylene	8.3229	—	0.3848
88	α-Copaene-8-ol	—	1579	3.28
89	α-Humulene	—	1453	0.75
90	α-Ionone	—	1421	4.04
91	α-Longipinene	—	1347	0.30
92	α-Selinene	—	1493	0.70
93	β-2--Pinene	11.853	—	0.3957
94	β-Bisabolene	—	1506	0.39
95	β-Caryophyllene	—	1416	1.62
96	β-Cyclocitral	—	1217	0.35
97	β-Homocyclocitral	—	1254	0.28
98	β-Ionone	—	1479	11.86
99	β-Selinene	—	1485	0.78
100	β-Vetivenene	—	1532	0.49
101	γ-Cadinene	—	1510	1.57
102	γ-Terpinen	18.2615	—	0.3824
103	γ-Terpinene	18.6552	—	2.415
104	δ-Cadinene	—	1516	2.37

RI: retention time; RI: retention indices.

4. Pharmacological Activities of the Genus Urtica

Except for U. dioica, which has extensively been studied for various pharmacological properties, few Urtica species have been investigated for their biological activity, including U. angustifolia, U. laetivirens, U. parviflora, U. dentata, U. pilulifera, U. mairei, U. membranacea, U. urens, U. circularis, U. hyperborean, U. cannabina, and U. thunbergiana that mostly displayed anti-inflammatory and antioxidant activities (Tables 1–13), and for antiviral, antimicrobial, antihelmintic, anticancer, nephroprotective, hepatoprotective, cardioprotective, antiarthritis, antidiabetic, antiendometriosis, and antiaging purposes (Figure 1)

Table 13

In vivo studies of the genus Urtica.

Extract/compound	Doses	Route of administration	Model	Effect	Reference
Antiarthritis effect
Total coumarins from Urtica dentata Hand	20, 40, 60 mg/kg	Orally every other day for 4 weeks after induction of arthritis	Collagen-induced arthritis BALB/c mice model	Dose-dependent ↓ arthritis score ↓paw swelling protect tissues against bone destruction ↓IFN-g, ↓IL-2 ↑IL-10, ↑TGF-B	[63]
Antioxidant effect
Total 80% ethanolic extract of Urtica dioica L. leaves	50, 100 mg/kg	Orally daily for 14 days	Normal Swiss albino mouse model	↑cytochrome b5, ↑NADH-cytochrome b5 reductase, ↑glutathione S-transferase, ↑DT-diaphorase, ↑glutathione peroxidase, ↑glutathione reductase, ↑superoxide dismutase, ↑catalase ↓cytochrome P450, ↓lactate dehydrogenase, ↓NADPH-cytochrome P450 reductase, ↓total sulfhydryl groups, ↓nonprotein sulfhydryl groups, ↓protein-bound sulfhydryl groups	[64]
Antidiabetic effect
Hexane, ethyl acetate and chloroform extracts of Urtica pilulifera	Two doses: 250 and 500 mg/kg	Orally daily for 4 weeks starting from day11 of diabetes induction	Streptozotocin and high-fat diet-induced type2 diabetes adult male albino rat model	Hypoglycemic effect - ethyl acetate and chloroform extracts ↓glucose level, ↓HbA1C, ↓ insulin resistance anti-inflammatory: ↓CRP, ↓TNF-α antioxidant: ↓MDA, ↑GSH, ↑SOD, ↑catalase	[65]
ZnO nanoparticles + aqueous extract of Urtica dioica leaves	ZnO + extract: 8 mg/dl	Intraperitoneally daily for 16 days	Alloxan-induced diabetic rat model	Both ZnO-extract and insulin (reference) ↓fasting blood glucose level in serum, while increased insulin level. ZnO-extract: ↑high-density lipoprotein ↓total cholesterol, ↓triglycerides	[66]
Antiendometriosis effect
Hexane, ethyl acetate and methanol extracts of Urtica dioica L. aerial parts	100 mg/kg	Orally for 4 weeks	Surgery-induced endometriosis rat model	Methanol extract: ↓implant volumes, ↓adhesion scores ↓TNF-α, ↓VEGF, ↓IL-6; histopathological outcomes supported the results	[67]
Effect on prostate hyperplasia
Polysaccharide fraction of Urtica fissa	62.5, 125, 250 mg/kg	Orally daily for 3 weeks	Testosterone propionate-induced prostate hyperplasia castrated rat model	↓prostate hyperplasia the lowest dose (62.5 mg/kg)-↓ indexes of wet weight,↓ dry weight , ↓volume by 17%, 23% and 32% highest dose (250 mg/kg)-↓indexes of wet weight, dry weight, ↓volume were further reduced by 25%, 33% and 37%; histopathological examination supported the results	[68]
Effect on nephrotoxicity
Total 95% ethanol extract of Urtica dioica	Dose: 100 mg/kg	Orally daily for 10 days	Gentamicin-induced nephrotoxicity in male rabbit model	↓ serum creatinine, ↓blood urea, ↓ nitrogen antioxidant-↑glutathione, ↓malondialdehyde	[69]
Antiviral effect
Urtica dioica agglutinin (UDA)	Three doses: 20, 10, 5 mg/kg	Intraperitoneally daily for 4 days	SARS-CoV- infected BALB/c mouse model	Treatment with UDA at dose 5 mg/kg significantly sheltered the mice against lethal infection with the virus but did not decrease virus titers in the lung; prevented weight loss and lung pathology scores of infected mice	[70]
Antiaging effect
Total extract (50% ethanol) of Urtica thunbergiana leaves	Two doses: 0.1% and 1% g/kg of the animals’ dry diet	Orally for 10 weeks	UVB-induced skin aging hairless mouse model	↓thinner and superficial wrinkles ↓erythema index ↑skin hydration; histopathological investigations supported the results	[71]
Anticancer effect
Dichloromethane extract of Urtica dioica	Two doses: 10 and 20 mg/kg	Intraperitoneally daily for 28 days	4T1 (breast cancer cell line) allograft tumor BALB/c mouse model	↓tumor size and weight. ↑apoptosis, ↓proliferation. ↓Bcl2, ↑caspase 3; histopathology examinations supported the results	[72]

Symbols: ↑ increase, ↓decrease.

[figure omitted; refer to PDF]

4.1. In Vitro Pharmacological Findings

4.1.1. Antiviral Activity

Antiviral treatment is limited to severe cases of most viral infections, stressing the need for more effective therapy. The aqueous extract of U. dioica fresh bark showed an antiviral effect against Petaluma virus (FIV-Pet) that infected Crandell feline kidney cell line (CrFK) by significantly inhibiting viral replication through reducing syncytia formation at low doses (0.5–1 g/ml) in a dose-dependent manner [73].

U. dioica extract (0.5–1 g/ml) and derived N-acetyl glucosamine-specific lectin (the 50% effective concentration (EC₅₀) for HIV ranged from 0.3 to 9 mg/ml) also revealed to be able to inhibit syncytium synthesis between CD4+ MOLT/4 cells and HUT-78 cells when infected by HIV-1 and HIV-2 (Uncini Manganelli, Zaccaro & Tomei, 2005). Also, the N-acetyl glucosamine-specific lectin from Urtica dioica was inhibitory to cytomegalovirus (CMV), respiratory syncytial virus (RSV), and influenza A virus-induced cytopathic at an EC₅₀ ranging from 0.3 to 9 mg/ml [74].

Another study showed that U. dioica agglutinin (UDA) suppressed the SARS-CoV virus replication by 90% at a concentration of 1.1 ± 0.4 ug/ml in Vero 76 cells by likely targeting the early stages of the replication phase through binding to the glycoprotein associated with the pseudotyped virus, thereby preventing the virus attachment to host cells [70].

4.1.2. Antimicrobial and Antifungal Activity

Despite the growing number of antimicrobials available, the rate of microorganisms with acquired drug resistance is alarming, and thus more research is needed to discover alternative therapies more effective and safer than the currently available ones [75, 76].

U. dioica ethanol and aqueous extracts showed antibacterial activity against both Gram-positive and Gram-negative bacteria and yeasts, including Proteus mirabilis, Pseudomonas aeruginosa, Enterobacter aerogenes, Escherichia coli, Citrobacter koseri, S. pneumonia, S. aureus, M. luteus, S. epidermidis, and Candida albicans. They were also active against M. tuberculosis in case of multiple drug resistance [77–79]. Of note, the aqueous (microwave-assisted, ultrasound-assisted, and subcritical water extraction) and ethanol extracts of U. dioica leaves also confirmed antibacterial activity with minimal inhibitory concentration (MIC) of 9.76 ug/mL and 0.0625–0.500 mg/ml against methicillin-resistant (MRSA) and methicillin-sensitive (MSSA) S. aureus strains [80]; these observed effects were linked to their high content of hydroxycinnamic acids (chlorogenic, caffeic, and rosmarinic acids) and flavonoids (quercetin) (Table 1) [81].

4.1.3. Anthelmintic Activity

The ethanolic extract of U. dioica displayed in vitro anthelmintic activity against protoscoleces of Echinococcus granulosus, increasing the concentration and duration of exposure, reaching 96.2% inhibition at a concentration of 4 μg/ml for 30 min (Table 1) [82]. Anthelmintic activity of the methanol extract was also investigated using adult Indian earthworms (Pheretima posthuma) and revealed a dose-dependent increase in anthelmintic activity at 25, 50, and 100 mg/mL [83].

4.1.4. Anticancer Activity

Cancer is the largest cause of death in the world due to poor timely access to high-quality diagnosis and treatment [84, 85]. U. dioica significantly suppressed the human breast cancer cell line (MCF-7) and fibroblasts secluded from foreskin tissue, with IC₅₀ values of MCF-7 (31.37 mg/ml), MDA-MB-23 (38.14 mg/ml), 4T1 (44.07 μg/mL to 35.21 mg/ml), and HFFF2 (69.42 mg/ml). QRT-PCR showed that U. dioica extracts inhibited cell migration by downregulating the expression of miR-21, matrix metalloproteinase (MMP) 1, MMP9, and MMP13, and C-X-C motif chemokine receptor 4 (CXCR4) and upregulating the expression of E-cadherin [86]. U. dioica leaves also increased cell apoptosis in 4T1 cells [72].

The aqueous extract of U. dioica leaves significantly decreased the cell proliferation of AML U937 cell line (acute myeloid leukemia), with IC₅₀ of 24 ug/ml for the first 48 h and then 16 ug/ml after 72 h [87]. Moreover, flow cytometry showed that the extract was able to stop the cell cycle into the G0 phase and increase cell apoptosis at the early and late stages by increasing proapoptotic protein Bax expression and decreasing antiapoptotic protein Bcl-2 expression [87].

Zekovic et al. reported the antiproliferative effect of the subcritical water extract of U. dioica against Hep2c, RD, and L2OB cells (13.42 ug/ml, 9.69 ug/ml, and 7.52 ug/ml, respectively) (Table 1) [80]. Moreover, the bioactive compound, 5a, 6b-dihydroxy-daucosterol, from U. laetevirens showed anticancer activity against MH7A cells by inhibiting proliferation and inducing apoptosis (Table 1) [88, 89].

4.1.5. Antioxidant Activity

Antioxidants are synthetic or natural compounds that can help to prevent or delay cell damage [90, 91]. The aqueous extract of U. dioica leaves presented antioxidant activity, assessed through the DPPH radical scavenging (IC₅₀ = 16.93 ug/mL), reducing power (EC₅₀ = 30.07 ug/mL) and polarographic (HPMC = 243.2%/mL) assays [80].

Batches of U. dioica analyzed for their antioxidant potency revealed batch 14 as the most potent (2.71 TEAC) using the CUPRAC assay and batch 27 (0.73 TEAC) using the FRAP assay. The resulting response surface plots approved a positive association between the antioxidant actions and the phenolic acids content [92]. A comparative study performed by Carvalho et al. demonstrated the superior antioxidant properties of U. dioica in all assays: DPPH (2.89 g/100 g lyophilized), ABTS (2.60 TEAC), and FRAP (3.81 TEAC) when compared to U. membranacea and U. urens aerial parts (Table 1) [89].

Methanol and direct-ethanol extracts of Urtica root showed free radical scavenging activity of 46.71% and 45.03% at 500 μg/ml, respectively. Moreover, Urtica parviflora (methanol/aqueous extract) has been reported for free radical scavenging and reducing activity, with biological activity varying in a dose-dependent manner. The antioxidant potential has also been reported in the ethanolic extracts of Urtica circularis, Urtica hyperborean (methanol extract), Urtica cannabina (polyphenols), and U. urens (Table 1) [93–96].

4.1.6. Anti-Inflammatory Activity

Although nonsteroidal medicines can be useful, herbs can be a safer and often effective alternative for pain management, especially when used for a long period [97]. U. dioica (leaves extract) and isolated flavonoids were active against thrombin-induced platelet aggregation (IC₅₀ values of 0.25 ± 0.05 and 0.40 ± 0.04 mg/ml) [98]. A comparative study between 50% ethanol extracts of U. dioica, U. membranacea, and U. urens aerial parts showed that U. urens extract (350 ug/mL) could act as a more potent anti-inflammatory agent by showing the highest reduction in nitric oxide production (up to 41%) (Table 1) [89].

4.1.7. Antiaging of Skin

Those who are prone to wrinkles and fine lines and those who have loose, sagging skin usually consider antiaging therapies [99]. Different extracts of U. dioica demonstrated antiaging efficacy using elastase and collagenase enzymes inhibition assay. The more potent batches were batch 1 that inhibited collagenase enzyme by 16.23% and batch 26 that inhibited elastase enzyme by 24.51%. This potency was linked to the high content of quercetin and ursolic acid, respectively (Table 1) [92].

4.2. In Vivo Pharmacological Findings

4.2.1. Antiviral Activity

U. diorca was also investigated for its in vivo antiviral potency. U. dioica agglutinin (UDA) at a dose of 5 mg/kg (b.w/day; i.p.) significantly sheltered the mice against lethal infection with the virus but did not decrease the virus titers in the lung of the SARS-CoV-infected BALB/c mouse model, also preventing the weight loss and lung pathology scores of infected mice [70] (Table 13).

4.2.2. Anthelmintic Activity

The fight against helminth infectious is still pending complete eradication either through a vaccine or pharmacological therapies. In vivo study showed that daily oral administration (175 mg/ml) of the methanol extract obtained from leaves and seeds of U. dioica showed anthelmintic activity in Swiss albino mice naturally infected with Aspiculuris tetraptera (Table 13) [100].

4.2.3. Anticancer Activity

The dichloromethane extract of U. dioica further showed anticancer activity by significantly reducing the tumor size and weight on 4T1 (breast cancer cell line) allograft tumor in BALB/c mouse model at 10 and 20 mg/kg b.w/day (i.p.). This efficacy was linked to increased cell apoptosis and suppression of cell proliferation through BCL2 downregulation and increased caspase-3 activity [72].

4.2.4. Nephroprotective

The kidney is a key organ of the metabolism of any xenobiotic; thus, preventing its alteration is crucial [101]. The 95% ethanol extract of U. dioica showed therapeutic action against nephrotoxicity on gentamicin-induced nephrotoxicity in the male rabbit model at a dose (100 mg/kg b.wt./day P.O.). The extract has a potent antioxidant activity through enhancing glutathione level and decreasing malondialdehyde level and helps in controlling serum creatinine and blood urea nitrogen levels [69]. Urtica parviflora extract (aerial parts) showed neuroprotective activity against nephrotoxicity induced by paracetamol and gentamicin and renal disability in Wistar rats and rabbits (Table 1) [77, 96].

4.2.5. Hepatoprotective

Because the liver is such an important part of any xenobiotic metabolism, preventing its alteration is also of utmost importance [102]. U. urens and U. dioica have been reported for their hepatoprotective activity against CCl4-induced liver toxicity in rats. For example, U. dioica (methanol extract) promoted an antioxidant system against cisplatin-induced toxicity in Ehrlich ascites tumor (mice model) and exerted hepatoprotective activity (Table 13) [83, 89].

4.2.6. Cardioprotective

Cardioprotection refers to all systems and methods that help keep the heart healthy by decreasing or even preventing myocardial damage [103]. U. dioica water and petroleum ether extract at, respectively, 20 and 150 mg/kg/day improved blood lipid level in rats, decreased blood cholesterol levels and LDL/HDL lipoprotein ratios after 30 days. On the other hand, U. dioica ethanol extract decreased cholesterol and LDL levels at a dose of 100 and 300 mg/kg [104, 105]. Urtica parviflora (350 and 500 mg/kg p.o.) effectively decreased cardiac complications and enhanced serum LDL level.

U. dioica aqueous extract (1 and 2 g/L) decreased heart rate and improved pressure in the left ventricle in Langendorff-perfused rat heart. It also improved the tolerance level of isolated rat heart against ischemia-reperfusion (Table 13) [106–108].

4.2.7. Antiarthritis Effect

Urtica species has also been shown to be effective for anti-inflammatory purposes, particularly in the treatment of arthritis. For example, a total coumarins extract from Urtica dentata demonstrated a dose-dependent antiarthritis activity in collagen-induced arthritis BALB /c mice model at three doses (20, 40, and 60 mg/kg b.w. P.O. every other day). Total coumarins also protected tissues against bone destruction by reducing IFN-g and IL-2 production and increasing IL-10 and TGF-B (Table 13) [63].

4.2.8. Antidiabetic Effect

Diabetes mellitus is a significant metabolic illness that can affect the central nervous system in a variety of ways, both functionally and morphologically [109]. Ethyl acetate and chloroform extracts of U. pilulifera showed antidiabetic activity at two doses (250 and 500 mg/kg b.w./day P.O.) on streptozotocin and high-fat diet-induced type 2 diabetes adult male albino rat model. Briefly, the extracts decreased glucose level, HbA1C percentage, and insulin resistance, with this hypoglycemic effect being associated with the anti-inflammatory effect through reducing C-reactive protein (CRP) levels in serum and TNF-a level and exerting antioxidant activity through decreasing MDA and increasing GSH levels, SOD, and catalase activities in pancreatic tissues (Table 13) [65]. Also, a formulation containing U. dioica, Artemisia judaica, Morus folium, Taraxacum officinale, and Canella winteriana has been reported to treat insulin-dependent (type I) and noninsulin-dependent (type II) diabetes. Furthermore, a lectin isolated from seeds of U. pilulifera exerted an antidiabetic impact on diabetic rats (streptozotocin (STZ) model) when administered for 30 days at a dose of 100 mg/kg. U. parviflora leaves (aqueous extract) also exerted hypoglycemic effect in normoglycemic rats, while U. angustifolia (leaves, stems, and roots) exerted hypoglycemic effects in a dose-dependent way (Table 13) [79, 110–112]. More recently, ZnO nanoparticles of aqueous extract from U. dioica leaves confirmed the antidiabetic activity of the combination (8 mg/dl. b.w./day I.P.) in an alloxan-induced diabetic rat model by significantly decreasing fasting blood glucose, total cholesterol, and total triglycerides levels in serum, while increasing high-density lipoprotein and insulin levels (Table 13) [66].

4.2.9. Antiendometriosis Effect

Endometriosis is a painful disorder in which tissue from the womb’s lining (uterus) is present both inside and outside the uterus. Some herbs may raise the risk of endometriosis, while others may help to heal it faster. The methanol extract of U. dioica aerial parts showed an antiendometriosis effect on the surgery-induced endometriosis rat model at a dose of 100 mg/kg b.wt./day P.O. by decreasing implant volumes and adhesion scores and peritoneal TNF-α, VEGF, and IL-6 levels as supported by histopathological outcomes (Table 13) [67].

4.2.10. Effect on Prostate Hyperplasia

Prostate enlargement, commonly known as benign prostatic hyperplasia (BPH), is a noncancerous increase in the size of the prostate gland. Prostatic hyperplasia was suppressed by a polysaccharide fraction of Urtica on testosterone propionate-induced prostate hyperplasia castrated rat model at three doses (62.5, 125, and 250 mg/kg b.wt. P.O.). Treatment with the lowest dose (62.5 mg/kg) reduced the indexes of wet weight, dry weight, and volume by 17%, 23%, and 32%, respectively. With the highest dose (250 mg/kg), the indexes of wet weight, dry weight, and volume were further reduced by 25%, 33%, and 37%, respectively (Table 13) [68].

Many herbal preparations from U. dioica extracts can inhibit 5-α-reductase [113]. Indeed, U. dioica roots (methanol extracts) were able to inhibit aromatase (AR) and 5a-reductase (5aRE) in a dose-dependent manner (ED₅₀ of 3.58 and 14.7 mg/mL, respectively). Urtica mairei (roots) reduced BPH and inhibited the activity of 5a-reductase (Table 13) [114, 115].

Hartmann et al. evaluated the effect of a combination between methylene chloride extract of Pygeum africanum bark and 30% methanol extract of U. dioica roots with a ratio of 1 : 12 (Prostatonin®) on BPH. This combination also significantly inhibited reductase and aromatase enzymes with ED₅₀ of 14.15 mg/ml and 0.24 mg/ml, respectively (Table 13) [116].

4.2.11. Antioxidant Activity

Antioxidants are widespread in the plant kingdom. For example, the 80% ethanol extract of U. dioica leaves confirmed antioxidant activity in a normal Swiss albino mouse model at two doses (50 and 100 mg/kg b.w./day P.O.). Both doses of the extract led to a marked increase in the activities of cytochrome b5, NADH-cytochrome b5 reductase, glutathione S-transferase, DT-diaphorase, glutathione peroxidase, glutathione reductase, superoxide dismutase, and catalase in liver tissues. On the other hand, they showed a reduction in cytochrome P450, lactate dehydrogenase, NADPH-cytochrome P450 reductase, total sulfhydryl groups, nonprotein sulfhydryl groups, and protein-bound sulfhydryl groups (Table 13) [64].

4.2.12. Anti-Inflammatory Activity

The discovery of new anti-inflammatory agents has long been a source of concern. The aqueous extract of U. dioica leaves showed analgesic effect at 1200 mg/kg by reducing thermal situation in a hot plate test (55°C), improving resistance to ache and hyperstimulation of the sensory nociceptors leading to TENS-like effect [94, 117].

The aerial part of U. urens (ethanol extract) inhibited 62.8% of the licking time during the final stage of the formalin test at a dose of 500 mg/kg in chemically induced mouse pain models [118, 119]. U. urens (methanol extract of aerial parts) at 100 to 400 mg/kg significantly displayed anxiolytic effect against mice model (Table 1) [120].

Furthermore, U. dioica aqueous extract (150 mg/kg dose) showed antipyretic activity in albino mice, while Urtica macrorrhiza aqueous extract (stem) decreased fever intensity in rats at 200 and 400 mg/kg [79, 121]. Indeed, it has been reported that U. dioica act by either blocking or interfering with chemical processes in the body related to chemicals found in the body, including dihydrotestosterone. In the carrageenan-induced paw edema model of rats, U. urens showed outstanding anti-inflammatory efficacy. Extract of its aerial parts revealed a percentage inhibition of 41.5% at 300 mg/kg i.p. in case of hind paw edema in rats. Moreover, petroleum ether extract of seeds of U. pilulifera and n-butanol and aqueous of U. macrorrhiza have also reported anti-inflammatory activity against carrageenan-induced paw edema in rats (Table 13) [111, 120, 122, 123]. In addition, some compounds from Urtica circularis, namely vicenin-2, caffeic acid, chlorogenic acid, and vitexin displayed a dose-dependent antinociceptive activity in nociceptive mice, in the following order of activity: vitexin (91%)> caffeic acid (41%) = vicenin-2 (41%)> chlorogenic acid (72%) (Table 13) [118, 119].

4.2.13. Antiaging of Skin

The use of natural plant extracts in the cosmetic industry as antiaging agents has received rising attention. Hwang et al. demonstrated the antiaging activity of the 50% ethanol extract of Urtica thunbergiana leaves on UVB-induced skin aging hairless mouse model at two doses (0.1% and 1% g/kg b.w. of animals’ diet). The extract (100 ug/mL) improved the aging disorders implied by UVB-irradiated NHDF, with ROS generation being reduced by 17%, MMP-1 and MMP-3 by 61% and 29%, respectively, and IL-6 secretion by 60%. Moreover, procollagen type 1 generation was upregulated by 255% and phosphorylation of ERK, JNK, and p38K was suppressed by 14%, 32%, and 38%, respectively. Dephosphorylation of NFAT was also inverted possibly due to the high content of chlorogenic acid in U. thunbergiana (Table 13) [71].

4.2.14. Diuretic and Antiurolithiatic Effects

U. dioica has traditionally been used as a diuretic in indigenous medicine. Experimentally, U. dioica (aqueous extract) possess natriuretic and diuretic activity in rabbits; the rate of K⁺ remains unaffected. U. dioica also revealed effectiveness against urinary infections. Indeed, its aerial part (methanol extract) also exerts antiurolithiatic potential can suppress the increased levels of urinary calcium and creatinine while significantly reducing the renal deposition of calcium and oxalate. U. dentata (n-butanol extract) also exert antiurolithiatic activity, prevent the deposition of calcium oxalate, and protect renal tissue from injury produced by kidney calculi (rat model) (Table 13) [112, 124].

4.3. Miscellaneous

The hypotensive activity of the methanol and water extract of U. dioica has also been shown in human cells culture and in vitro models of prostatic antihyperplasic activity [125]. U. dioica aqueous extract has been revealed to exert good in vivo antiulcer efficacy against ethanol-induced ulcers [113], while leaves and seed extract (400 µg/mL) possess in vitro immunomodulatory potential (Table 13) [47, 126]. Finally, U. angustifolia (polysaccharides) showed antifatigue properties in mice [112].

5. Health-Promoting Effects: Clinical Trial Findings

5.1. Anti-Inflammatory Effect

Earlier literature reported that the administration of 1340 mg of powdered extract of U. dioica (nettle leaves) reduced arthritis to half. A randomized control trial in 50 patients suffering from a chronic joint disease in Germany demonstrated the effectiveness of a combination of stewed nettle along with 50 mg of diclofenac treatment (group D50+U) compared to a standard dose of diclofenac (200 mg) [127, 128]. Results of this study indicated that both treatments were equally effective in mitigating clinical symptoms occurring due to acute arthritis. These results are of great importance for patients who suffer from nonsteroidal anti-inflammatory drugs (NSAIDs) intolerance because of ulceration or other gastric problems. However, further studies are required to find out whether nettle could be effective in the absence of NSAIDs [127, 129].

5.2. Diuretic Effect

In a study aiming to assess the impact of 15 mL nettle herb juice for treating myocardial or chronic insufficiency, 32 patients received 3 times daily such preparation in an open 2-week study. Later, the frequency of dosing was reduced to once a day in the morning. The daily volume of urine was increased significantly throughout the treatment. The patients with myocardial insufficiency in the 2^nd day of treatment was 9.2% higher ($p\le 0.0005$) than the baseline and patients of chronic venous insufficiency reported 23.9% higher ($p\le 0.05$) urine volume. Patients’ weight (about 1%) and systolic blood pressure showed slight decreases. Apart from slight side effects, like diarrhea, serum parameters remained stable and treatments were smoothly tolerated. Additionally, diuretic and natriuretic effects were detected, implying a renal function effect [127, 130]. Some objective indicators in this clinical investigation indicated statistically significant improvement, despite the small number of patients and the short duration of the study limiting the establishment of solid conclusions.

5.3. Antiallergic Effect

The safest remedy for allergy and sinus treatment is nettle. Indeed, it has been reported used in various ailments ranging from allergic rhinitis to hypertension. Lyophilized leaves of nettle have been clinically proven to relieve allergy symptoms [89, 113]. For example, a double-blind, randomized study was conducted with 98 individuals to try the effect of freeze-dried U. dioica herb (2 times 300 mg) on allergic rhinitis. After one week of therapy, daily symptom diaries and global response documented after follow-up were considered for assessment [131, 132]. In the overall evaluations, U. dioica was ranked higher than placebo, and when the diary data were compared, U. dioica was just marginally higher [132]. Thus, even if the U. dioica trial appears to be effective, more research with a bigger and better-matched sample size and possibly a longer treatment period might be beneficial. Research into the mechanism of action of U. dioica and its potential for application in other allergy disorders is also recommended.

5.4. Antidiabetic Effect

The health benefit of the hydroalcoholic extract of U. dioica on blood lipids, hepatic enzymes, and nitric oxide levels was investigated in a randomized control trial, including 50 women with type 2 diabetes. U. dioica significantly decreased FPG and TG and increased SGPT levels and HDL, NO, and SOD levels compared to the control group after 8 weeks of treatment. This result supports using the hydroalcoholic extract of U. dioica as an antioxidant agent for additional therapy of diabetes to minimize complications, such as cardiovascular risk factors in diabetic patients [133]. However, the relatively small sample size and the lack of exact diet and exercise management of patients who participated in the study make the findings suggestive rather than conclusive. Therefore, trials with a larger number of patients and a longer intervention period are recommended to better understand U. dioica’s benefits in diabetic patients.

Overall, these clinical studies are not appropriate for traditional use in indications, like the acute attack of chronic joint disease, myocardial or chronic venous insufficiency, and allergic rhinitis. Indeed, only the well-established use can be relevant in these indications; however, they are hardly good enough and the results of these trials cannot be used [134].

Since a small number of participants were included in the studies and were not double-blind (except Mittman’s study) and that data are not detailed enough, the consequences are not influential. These studies may only support the authenticity of diuretic and anti-inflammatory effects; in this way, the traditional indications may be supported by them.

6. Safety, Drug-Drug Interaction, and Adverse Effect of the Genus Urtica

Though sweating and gastric discomfort are reported in some cases, the Urtica plant usually causes skin irritation upon touching it [135].

Hypersensitivity cases have been reported in patients with renal ailments [33, 130]. When the hairs or spines on the stems and leaves of the stinging nettle come into contact with the skin, various physiologically active chemicals are released within seconds and in turn induce irritation, dermatitis, and urticaria [136]. These findings imply that histamine, which is released by the nettle, has a role in the rapid reaction to nettle stings. Moreover, the endurance of the stinging sensation, on the other hand, could indicate that there are chemicals in nettle fluid that are directly harmful to nerves or that can cause the subsequent release of other mediators [137]. Furthermore, urine flow is enhanced by the aerial parts of Urtica; hence, it is advised to inform the healthcare provider of whether the patient suffers from diabetes or kidney problems [33, 130]. Urtica aerial parts at 1.25 g/kg decline blood sugar following intake [135] and may potentiate concurrent antidiabetics’ effect, high or low blood pressure [138–140].

Furthermore, the key underlying processes of this food plant and its phytonutrients in the management of urolithiasis include a diuretic effect, which can exacerbate the diuretic therapy in patients with renal disorders. Though nettle is reputed to be an abortifacient and to affect the menstrual cycle in traditional medicine, oral administration of 250 mg/kg of nettle to mice is devoid of antifertility activity. In the absence of clear evidence of antifertility potency, Urtica spp. should be completely avoided during pregnancy or in breastfeeding women and children [127]. For sure, Urtica dioica and Urtica urens preparations have been used orally as a postpartum “tonic” for treating anemia in nursing mothers and is a purported galactagogue. Still, no scientifically valid clinical trials support the safety and efficacy in nursing mothers or infants for any use [141].

Urtica dioica is used as an anti-inflammatory in rheumatoid arthritis. The anti-inflammatory effect of Urtica extract is due to its inhibitory effect on NF-kappaB activation and the genetic transcription factor that activates TNF-α and IL-1B in synovial tissue that lines the joint, lowering TNF-α and other inflammatory cytokines levels [123, 142]. Therefore, Urtica spp. should be avoided in the case of acute arthritis due to the risk of drug-drug interaction [138].

Urtica spp. has also been reported to enhance the impact of CNS depressant medications [138]. The concomitant use of Urtica aerial parts with sedatives, including lorazepam (Ativan), phenobarbital (Donnatal), clonazepam (Klonopin), zolpidem (Ambien), and others may lead to sleepiness and drowsiness [127].

7. Conclusions and Future Perspectives

In short, while summarizing the ethnopharmacological reports on the use of Urtica species, U. dioica emerged as the most reported species, providing a rich source of active principles for developing novel treatment strategies. Despite its ancient use by people from different cultures and in different regions for the treatment of various ailments, the current achievements have stated that Urtica spp. have renowned pharmacological potentialities, including anti-inflammatory, anticancer, antioxidant, antidiabetic, antimicrobial, and antiviral effects that correlate, by one hand, with some traditional uses and, on the other hand, with the bioactive phytochemicals present, including phenolic compounds and terpenoids that may be effectively applied for preventive or therapeutic purposes in communicable and noncommunicable diseases. However, there is still a large gap in in vivo experiments and clinical trials using plant-based preparations or isolated phytochemicals from Urtica spp. that need to be filled in a short time so that new windows for preventive, therapeutic, and agroindustrial purposes can be open.

Authors’ Contributions

All the authors made a significant contribution to the work reported, whether that is in the conception, study design, execution, acquisition of data, analysis, and interpretation, or in all these areas: that is, revising or critically reviewing the article; giving final approval of the version to be published; agreeing on the journal to which the article has been submitted; and confirming to be accountable for all aspects of the work. All the authors have read and agreed to the published version of the manuscript.

References

[1] K. M. Ahmed, S. J. S. R. I. P. Parsuraman, "Urtica dioica L.,(Urticaceae): a stinging nettle," Systematic Reviews in Pharmacy, vol. 5 no. 1, 2014.

[2] D. Kregiel, E. Pawlikowska, H. Antolak, "Urtica spp: ordinary plants with extraordinary properties," Molecules, vol. 23 no. 7, 2018.

[3] J. Mutke, R. Jacobs, K. Meyers, T. Henning, M. Weigend, "Diversity patterns of selected andean plant groups correspond to topography and habitat dynamics, not orogeny," Frontiers in Genetics, vol. 5 no. 351,DOI: 10.3389/fgene.2014.00351, 2014.

[4] M. Weigend, A. K. Monro, "Urtica L. (Urticaceae)," Flora Mesoamericana, pp. 171-174, 2015.

[5] G. Hashimoto, "Brazil," Biology and Ecology of Weeds, pp. 333-337, DOI: 10.1007/978-94-017-0916-3_29, 1982.

[6] M. Srlltek, M. Teckelmann, "Review of biology and ecology of Urtica dioica," Preslia Praha, vol. 70, 1998.

[7] B. Grosse-Veldmann, M. Weigend, "Weeding the nettles III: named nonsense versus named morphotypes in European Urtica dioica L. (Urticaceae)," Phytotaxa, vol. 208 no. 4,DOI: 10.11646/phytotaxa.208.4.1, 2015.

[8] B. Grosse-Veldmann, B. J. Conn, M. Weigend, "Weeding the nettles IV: a redefinition of Urtica incisa and allies in New Zealand and Australia, including the segregation of two new species Urtica sykesii and U. perconfusa," Phytotaxa, vol. 245 no. 4,DOI: 10.11646/phytotaxa.245.4.2, 2016.

[9] B. Grosse-Veldmann, N. M. Nürk, R. Smissen, I. Breitwieser, D. Quandt, M. Weigend, "Pulling the sting out of nettle systematics-a comprehensive phylogeny of the genus Urtica L. (Urticaceae)," Molecular Phylogenetics and Evolution, vol. 102,DOI: 10.1016/j.ympev.2016.05.019, 2016.

[10] M. Weigend, A. Cano, E. F. Rodríguez, "New species and new records of the flora in amotape-huancabamba zone: endemics and biogeographic limits," Revista Peruana de Biologia, vol. 12 no. 2, pp. 249-274, 2005.

[11] A. Kumar, A. Singh Bisht, S. Joshi, D. Juyal, "Pharmacognostical and phytochemical study of a plant Urtica parviflora Roxb.—a review," Journal of Pharmacognosy and Phytochemistry, vol. 6 no. 3, pp. 42-45, 2017.

[12] Y. Yeşil, İ. İnal, "Traditional knowledge of wild edible plants in hasankeyf (Batman Province, Turkey)," Acta Societatis Botanicorum Poloniae, vol. 88 no. 3, 2019.

[13] Y. Yesil, M. Celik, B. Yilmaz, "Wild edible plants in yesilli (Mardin-Turkey), a multicultural area," Journal of Ethnobiology and Ethnomedicine, vol. 15 no. 1, 2019.

[14] F. Varga, I. Šolić, M. J. Dujaković, Ł. Łuczaj, M. Grdiša, "The first contribution to the ethnobotany of inland dalmatia: medicinal and wild food plants of the Knin area, Croatia," Acta Societatis Botanicorum Poloniae, vol. 88 no. 2,DOI: 10.5586/asbp.3622, 2019.

[15] A. A. Samaha, M. Fawaz, A. Salami, S. Baydoun, A. H. Eid, "Antihypertensive indigenous lebanese plants: ethnopharmacology and a clinical trial," Biomolecules, vol. 9 no. 7,DOI: 10.3390/biom9070292, 2019.

[16] Ş. Kültür, G. Melikoglu, S. Kurtoglu, O. Altınbaşak, "Türkiye de mide ülserinde kullanılan tıbbi bitkiler," Marmara Pharmaceutical Journal, vol. 22 no. 1, 2018.

[17] I. Vitasovic Kosic, J. Juracak, L. Luczaj, "Using ellenberg-pignatti values to estimate habitat preferences of wild food and medicinal plants: an example from northeastern Istria (Croatia)," Journal of Ethnobiology and Ethnomedicine, vol. 13 no. 1, 2017.

[18] Ç. Kizilarslan Hançer, E. Sevgi, B. Büyükkılıç, E. Çakir, M. Akkaya, "Traditional knowledge of wild edible plants of biga (çanakkale), Turkey," Acta Societatis Botanicorum Poloniae, vol. 89 no. 1, 2020.

[19] M. Ibrahim, K. Rehman, A. Razzaq, I. Hussain, T. Farooq, A. Hussain, M. S. H. Akash, "Investigations of phytochemical constituents and their pharmacological properties isolated from the genus Urtica: critical review and analysis," Critical Reviews in Eukaryotic Gene Expression, vol. 28 no. 1, pp. 25-66, 2018.

[20] İ. Gürbüz, A. Gençler Ozkan, T. Günbatan, F. Demirci, E. Yesilada, "Folk medicine in düzce province (Turkey)," Turkish Journal of Botany, vol. 43 no. 6, pp. 769-784, 2019.

[21] P. M. Guarrera, V. Savo, "Wild food plants used in traditional vegetable mixtures in Italy," Journal of Ethnopharmacology, vol. 185, pp. 202-234, DOI: 10.1016/j.jep.2016.02.050, 2016.

[22] U. Koca, C. Aka Dönmez, M. G. Oz, "Plants used in anatolian traditional medicine for the treatment of hemorrhoid," Records of Natural Products, vol. 11, pp. 235-250, 2017.

[23] K. Dolina, M. Jug-Dujaković, Ł. Łuczaj, I. Vitasović-Kosić, "A century of changes in wild food plant use in coastal croatia: the example of krk and poljica," Acta Societatis Botanicorum Poloniae, vol. 85 no. 3, pp. 3508-3529, DOI: 10.5586/asbp.3508, 2016.

[24] H. Bhatia, Y. P. Sharma, R. K. Manhas, K. Kumar, "Traditionally used wild edible plants of district Udhampur, J and K, India," Journal of Ethnobiology and Ethnomedicine, vol. 14,DOI: 10.1186/s13002-018-0272-1, 2018.

[25] M. Asadi-Samani, M.-T. Moradi, L. Mahmoodnia, S. Alaei, F. Asadi-Samani, T. Luther, "Traditional uses of medicinal plants to prevent and treat diabetes; an updated review of ethnobotanical studies in Iran," Journal of Nephropathology, vol. 6 no. 3, pp. 118-125, DOI: 10.15171/jnp.2017.20, 2017.

[26] M. S. Abu-Darwish, T. Efferth, "Medicinal plants from near east for cancer therapy," Frontiers in Pharmacology, vol. 9 no. 56,DOI: 10.3389/fphar.2018.00056, 2018.

[27] J. Sharifi-Rad, C. Quispe, J. Herrera-Bravo, M. Akram, W. Abbaass, P. Semwal, S. Painuli, D. Alekseevich Konovalov, M. A. Alfred, N. V. Anil Kumar, M. Imran, M. Nadeem, B. Sawicka, P. Pszczółkowski, B. Bienia, P. Barbaś, S. Mahmud, A. Durazzo, M. Lucarini, A. Santini, M. Martorell, D. Calina, "Phytochemical constituents, biological activities, and health-promoting effects of the melissa officinalis," Oxidative Medicine and Cellular Longevity, vol. 2021,DOI: 10.1155/2021/6584693, 2021.

[28] R. Hossain, C. Quispe, J. Herrera-Bravo, S. Islam, C. Sarkar, M. Torequl Islam, M. Martorell, N. Cruz-Martins, A. Al-Harrasi, A. Al-Rawahi, J. Sharifi-Rad, M. Ibrayeva, S. Durna Daştan, M. M. Alshehri, D. Calina, W. C. Cho, "Lasia spinosa chemical composition and therapeutic potential: a literature-based review," Oxidative Medicine and Cellular Longevity, vol. 2021,DOI: 10.1155/2021/1602437, 2021.

[29] M. Hejcman, M. Češková, J. Schellberg, S. Pätzold, "The rengen grassland experiment: effect of soil chemical properties on biomass production, plant species composition and species richness," Folia Geobotanica, vol. 45 no. 2, pp. 125-142, DOI: 10.1007/s12224-010-9062-9, 2010.

[30] C. D. Pigott, K. Taylor, "The distribution of some woodland herbs in relation to the supply of nitrogen and phosphorus in the soil," The Journal of Animal Ecology, vol. 33,DOI: 10.2307/2438, 1964.

[31] C. Olsen, "The ecology of urtica dioica," The Journal of Ecology, vol. 9 no. 1,DOI: 10.2307/2255757, 1921.

[32] G. Corsi, A. Masini, Anatomical and Ecological Aspects in Italian Taxa of the Genus Urtica, 1997.

[33] L. Testai, S. Chericoni, V. Calderone, G. Nencioni, P. Nieri, I. Morelli, E. Martinotti, "Cardiovascular effects of Urtica dioica L. (Urticaceae) roots extracts: in vitro and in vivo pharmacological studies," Journal of Ethnopharmacology, vol. 81 no. 1, pp. 105-109, DOI: 10.1016/s0378-8741(02)00055-7, 2002.

[34] I. Friis, "Urticaceae," Flowering Plants Dicotyledons, pp. 612-630, DOI: 10.1007/978-3-662-02899-5_76, 1993.

[35] D. Geltman, "Urtica galeopsifolia wierzb. ex opiz (Urticaceae) in wicken Fen (E. England)," Watsonia, vol. 19, 1992.

[36] E. Hultén, M. Fries, Atlas of North European Vascular Plants, 1986.

[37] J. P. Grime, J. G. Hodgson, R. Hunt, Comparative Plant Ecology: A Functional Approach to Common British Species, 1989.

[38] C. Stefanescu, "The nature of migration in the red admiral butterfly vanessa atalanta: evidence from the population ecology in its southern range," Ecological Entomology, vol. 26 no. 5, pp. 525-536, DOI: 10.1046/j.1365-2311.2001.00347.x, 2001.

[39] P. B. Hardy, R. L. H. Dennis, "The impact of urban development on butterflies within a city region," Biodiversity and Conservation, vol. 8 no. 9, pp. 1261-1279, DOI: 10.1023/a:1008984905413, 1999.

[40] S. Bryant, C. Thomas, J. Bale, "Nettle-feeding nymphalid butterflies: temperature, development and distribution," Ecological Entomology, vol. 22 no. 4, pp. 390-398, DOI: 10.1046/j.1365-2311.1997.00082.x, 1997.

[41] B. N. K. Davis, "The European distribution of insects on stinging nettles, Urtica dioica L: a field survey," Bolletino di Zoologia, vol. 56 no. 4, pp. 321-326, DOI: 10.1080/11250008909355658, 1989.

[42] S. R. Bryant, C. D. Thomas, J. S. Bale, "Thermal ecology of gregarious and solitary nettle-feeding nymphalid butterfly larvae," Oecologia, vol. 122 no. 1,DOI: 10.1007/pl00008825, 2000.

[43] J. Sharifi-Rad, A. Bahukhandi, P. Dhyani, P. Sati, E. Capanoglu, A. O. Docea, A. Al-Harrasi, A. Dey, D. Calina, "Therapeutic potential of neoechinulins and their derivatives: an overview of the molecular mechanisms behind pharmacological activities," Frontiers in Nutrition, vol. 8,DOI: 10.3389/fnut.2021.664197, 2021.

[44] J. Sharifi-Rad, C. Quispe, J. Herrera-Bravo, M. Martorell, F. Sharopov, T. B. Tumer, B. Kurt, C. Lankatillake, A. Oana Docea, A. Catarina Moreira, D. A. Dias, M. Fawzi Mahomoodally, D. Lobine, N. Cruz-Martins, M. Kumar, D. Calina, "A pharmacological perspective on plant-derived bioactive molecules for epilepsy," Neurochemical Research, vol. 46 no. 9, 2021.

[45] F. Abe, "The CDF detector: an overview," Nuclear Instruments and Methods in Physics Research Section A: Accelerators, Spectrometers, Detectors and Associated Equipment, vol. 271 no. 3, pp. 387-403, 1988.

[46] H. Aishan, M. Baba, N. Iwasaki, H. Kuang, T. Okuyama, "The constituents of Urtica cannabina used in uighur medicine," Pharmaceutical Biology, vol. 48 no. 5, pp. 577-583, DOI: 10.3109/13880200903214215, 2010.

[47] P. Akbay, A. A. Basaran, U. Undeger, N. Basaran, "In vitro immunomodulatory activity of flavonoid glycosides from Urtica dioica L," Phytotherapy Research, vol. 17 no. 1, pp. 34-37, DOI: 10.1002/ptr.1068, 2003.

[48] J. Asgarpanah, R. Khoshkam, "Phytochemistry and pharmacologic properties of Urtica dioica L," Journal of Medicinal Plants Research, vol. 6,DOI: 10.5897/jmpr12.040, 2012.

[49] H. Bhatia, R. K. Manhas, K. Kumar, R. Magotra, "Traditional knowledge on poisonous plants of Udhampur district of Jammu and Kashmir, India," Journal of Ethnopharmacology, vol. 152 no. 1, pp. 207-216, DOI: 10.1016/j.jep.2013.12.058, 2014.

[50] A. N. Binns, R. H. Chen, H. N. Wood, D. G. Lynn, "Cell division promoting activity of naturally occurring dehydrodiconiferyl glucosides: do cell wall components control cell division?," Proceedings of the National Academy of Sciences, vol. 84 no. 4, pp. 980-984, DOI: 10.1073/pnas.84.4.980, 1987.

[51] M. Ekor, "The growing use of herbal medicines: issues relating to adverse reactions and challenges in monitoring safety," Frontiers in Pharmacology, vol. 4,DOI: 10.3389/fphar.2013.00177, 2014.

[52] M. A. Farag, M. Weigend, F. Luebert, G. Brokamp, L. A. Wessjohann, "Phytochemical, phylogenetic, and anti-inflammatory evaluation of 43 Urtica accessions (stinging nettle) based on UPLC-Q-TOF-MS metabolomic profiles," Phytochemistry, vol. 96, pp. 170-183, DOI: 10.1016/j.phytochem.2013.09.016, 2013.

[53] B. Feng, X. Yan, H. Wang, L. Shi, L. Tang, Y. Wang, "Two new secolignan glycosides from the roots of Urtica triangularis hand.-mazz," Fitoterapia, vol. 81 no. 6, pp. 607-609, DOI: 10.1016/j.fitote.2010.03.002, 2010.

[54] S. Kumar, S. Ahmad, S. Harikumar, "Pharmacognostical and pharmacological studies on urtica parviflora roxb. A review," International Journal of Universal Pharmacy and Bio Sciences, vol. 3 no. 4, pp. 179-184, 2014.

[55] E. S. Lapinskaya, Y. F. Kopyt’ko, E. A. Timokhina, B. A. Krapivkin, G. S. Levandovskii, T. D. Dargaeva, T. A. Sokol’skaya, "Amino acids and cyclic dipeptides in stinging nettle ( Urtica dioica and U. urens) homeopathic matrix tinctures," Pharmaceutical Chemistry Journal, vol. 42 no. 11, pp. 650-653, DOI: 10.1007/s11094-009-0189-z, 2009.

[56] J. Ma, X. Jin, L. Yang, Z. L. Liu, "Diarylheptanoids from the rhizomes of zingiber officinale," Phytochemistry, vol. 65 no. 8, pp. 1137-1143, DOI: 10.1016/j.phytochem.2004.03.007, 2004.

[57] C. Rice-Evans, N. Miller, G. Paganga, "Antioxidant properties of phenolic compounds," Trends in Plant Science, vol. 2 no. 4, pp. 152-159, DOI: 10.1016/s1360-1385(97)01018-2, 1997.

[58] M. Tekin, H. Özbek, A. Him, "Investigation of acute toxicity, anti-inflammatory and analgesic effect of Urtica dioica L," Pharmacologyonline, vol. 1, pp. 1210-1215, 2009.

[59] N. A. Yunuskhodzhaeva, V. N. Abdullabekova, K. S. Ibragimova, L. G. Mezhlumyan, "Amino-acid composition of Urtica dioica leaves and Polygonum hydropiper and P. aviculare herbs," Chemistry of Natural Compounds, vol. 50 no. 5, pp. 970-971, DOI: 10.1007/s10600-014-1137-z, 2014.

[60] R. Dhouibi, H. Affes, M. Ben Salem, S. Hammami, Z. Sahnoun, K. M. Zeghal, K. Ksouda, "Ksouda, Screening of pharmacological uses of Urtica dioica and others benefits," Progress in Biophysics and Molecular Biology, pp. 67-77, 2020.

[61] S. Sitrallah, J. Merza, "Chemical composition of essential oil extracted from urtica pilulifera and evaluation its biological activity," Food Science and Quality Management, vol. 78, pp. 44-48, 2018.

[62] D. C. Ilies, I. Tudor, V. Radulescu, "Chemical composition of the essential oil of Urtica dioica," Chemistry of Natural Compounds, vol. 48 no. 3, pp. 506-507, DOI: 10.1007/s10600-012-0291-4, 2012.

[63] X. Luo, L.-L. Li, S.-S. Zhang, J.-L. Lu, Y. Zeng, H.-Y. Zhang, M. Xiang, "Therapeutic effects of total coumarins from Urtica dentata Hand on collagen-induced arthritis in Balb/c mice," Journal of Ethnopharmacology, vol. 138 no. 2, pp. 523-529, DOI: 10.1016/j.jep.2011.09.050, 2011.

[64] T. Ozen, H. Korkmaz, "Modulatory effect of Urtica dioica L. (Urticaceae) leaf extract on biotransformation enzyme systems, antioxidant enzymes, lactate dehydrogenase and lipid peroxidation in mice," Phytomedicine, vol. 10 no. 5, pp. 405-415, DOI: 10.1078/0944-7113-00275, 2003.

[65] D. M. Abo-elmatty, S. S. Essawy, J. M. Badr, O. Sterner, "Antioxidant and anti-inflammatory effects of Urtica pilulifera extracts in type2 diabetic rats," Journal of Ethnopharmacology, vol. 145 no. 1, pp. 269-277, DOI: 10.1016/j.jep.2012.11.002, 2013.

[66] A. Bayrami, S. Haghgooie, S. R. Pouran, F. M. Arvanag, A. Habibi-Yangjeh, "Synergistic antidiabetic activity of ZnO nanoparticles encompassed by Urtica dioica extract," Advanced Powder Technology, vol. 31 no. 5,DOI: 10.1016/j.apt.2020.03.004, 2020.

[67] M. Ilhan, Z. Ali, I. A. Khan, H. Taştan, E. Küpeli Akkol, "Bioactivity-guided isolation of flavonoids from Urtica dioica L. and their effect on endometriosis rat model," Journal of Ethnopharmacology, vol. 243,DOI: 10.1016/j.jep.2019.112100, 2019.

[68] Q. Zhang, L. Li, L. Liu, Y. Li, L. Yuan, L. Song, Z. Wu, "Effects of the polysaccharide fraction of Urtica fissa on castrated rat prostate hyperplasia induced by testosterone propionate," Phytomedicine, vol. 15 no. 9, pp. 722-727, DOI: 10.1016/j.phymed.2007.12.005, 2008.

[69] S. A. Nadia, "Effect of nettle ( Urtica dioica ) extract on gentamicin induced nephrotoxicity in male rabbits," Asian Pacific Journal of Tropical Biomedicine, vol. 9, pp. 729-732, 2015.

[70] Y. Kumaki, M. K. Wandersee, A. J. Smith, Y. Zhou, G. Simmons, N. M. Nelson, K. W. Bailey, Z. G. Vest, J. K.-K. Li, P. K.-S. Chan, D. F. Smee, D. L. Barnard, "Inhibition of severe acute respiratory syndrome coronavirus replication in a lethal SARS-CoV BALB/c mouse model by stinging nettle lectin, Urtica dioica agglutinin," Antiviral Research, vol. 90 no. 1, pp. 22-32, DOI: 10.1016/j.antiviral.2011.02.003, 2011.

[71] E. Hwang, H. T. T. Ngo, S. A. Seo, B. Park, M. Zhang, W. Gao, T. Hoo Yi, "Urtica thunbergiana prevents UVB-induced premature skin aging by regulating the transcription factor NFATc1: an in vitro and in vivo study," Journal of Functional Foods, vol. 36, pp. 162-177, DOI: 10.1016/j.jff.2017.07.004, 2017.

[72] A. Mohammadi, B. Mansoori, P. C. Baradaran, V. Khaze, M. Aghapour, M. Farhadi, B. Baradaran, "Urtica dioica extract inhibits proliferation and induces apoptosis and related gene expression of breast cancer cells in vitro and in vivo," Clinical Breast Cancer, vol. 17 no. 6, pp. 463-470, DOI: 10.1016/j.clbc.2017.04.008, 2017.

[73] R. E. Uncini Manganelli, L. Zaccaro, P. E. Tomei, "Antiviral activity in vitro of Urtica dioica L., Parietaria diffusa M. et K. and Sambucus nigra L," Journal of Ethnopharmacology, vol. 98 no. 3, pp. 323-327, 2005.

[74] J. Balzarini, J. Neyts, D. Schols, M. Hosoya, E. Van Damme, W. Peumans, E. De Clercq, "The mannose-specific plant lectins from cymbidium hybrid and epipactis helleborine and the (N-acetylglucosamine)n-specific plant lectin from Urtica dioica are potent and selective inhibitors of human immunodeficiency virus and cytomegalovirus replication in vitro," Antiviral Research, vol. 18 no. 2, pp. 191-207, DOI: 10.1016/0166-3542(92)90038-7, 1992.

[75] Y. Taheri, N. Joković, J. Vitorović, O. Grundmann, A. Maroyi, D. Calina, "The burden of the serious and difficult-to-treat infections and a new antibiotic available: cefiderocol," Frontiers in Pharmacology, vol. 11,DOI: 10.3389/fphar.2020.578823, 2021.

[76] O. Zlatian, A. T. Balasoiu, M. Balasoiu, O. Cristea, A. O. Docea, R. Mitrut, D. A. Spandidos, A. M. Tsatsakis, G. Bancescu, D. Calina, "Antimicrobial resistance in bacterial pathogens among hospitalised patients with severe invasive infections," Experimental and Therapeutic Medicine, vol. 16 no. 6, pp. 4499-4510, DOI: 10.3892/etm.2018.6737, 2018.

[77] R. Singh, S. Hussain, R. Verma, P. Sharma, "Anti-mycobacterial screening of five Indian medicinal plants and partial purification of active extracts of cassia sophera and Urtica dioica," Asian Pacific Journal of Tropical Medicine, vol. 6 no. 5, pp. 366-371, DOI: 10.1016/s1995-7645(13)60040-1, 2013.

[78] A. Modarresi-Chahardehi, D. Ibrahim, S. Fariza-Sulaiman, L. Mousavi, "Screening antimicrobial activity of various extracts of Urtica dioica," Revista de Biologia Tropical, vol. 60, pp. 1567-1576, 2012.

[79] S. A. Dar, F. A. Ganai, A. R. Yousuf, M.-u.-H. Balkhi, T. M. Bhat, P. Sharma, "Pharmacological and toxicological evaluation of Urtica dioica," Pharmaceutical Biology, vol. 51 no. 2, pp. 170-180, DOI: 10.3109/13880209.2012.715172, 2013.

[80] Z. Zeković, A. Cvetanović, J. Švarc-Gajić, S. Gorjanović, D. Sužnjević, P. Mašković, S. Savić, M. Radojković, S. Đurović, "Chemical and biological screening of stinging nettle leaves extracts obtained by modern extraction techniques," Industrial Crops and Products, vol. 108, pp. 423-430, 2017.

[81] S. Zenão, A. Aires, C. Dias, M. Saavedra, C. Fernandes, "Antibacterial potential of Urtica dioica and Lavandula angustifolia extracts against methicillin resistant staphylococcus aureus isolated from diabetic foot ulcers," Journal of Herbal Medicine, vol. 10, pp. 53-58, 2017.

[82] L. Ommar, "The anthelmintic effect of urtica dioica and tanacetum vulgare L. On protoscoleces of echinococcus granulosus," International Journal of Sciences: Basic and Applied Research (IJSBAR), vol. 11 no. 1, pp. 84-89, 2013.

[83] M. Sarma Kataki, V. Murugamani, A. Rajkumari, P. Mehra, D. Awasthi, R. Yadav, "Antioxidant, hepatoprotective, and anthelmintic activities of methanol extract of urtica dioica L. Leaves," Pharmaceutical Crops, vol. 3 no. 1,DOI: 10.2174/2210290601203010038, 2012.

[84] J. Sharifi-Rad, C. Quispe, J. Kumar Patra, Y. Disco Singh, M. Kumar Panda, G. Das, C. Oluwaseun Adetunji, O. Samuel Michael, O. Sytar, L. Polito, J. Živković, N. Cruz-Martins, M. Klimek-Szczykutowicz, H. Ekiert, M. I. Choudhary, S. A. Ayatollahi, B. Tynybekov, F. Kobarfard, A. C. Muntean, I. Grozea, S. D. Daştan, M. Butnariu, A. Szopa, D. Calina, "Paclitaxel: application in modern oncology and nanomedicine-based cancer therapy," Oxidative Medicine and Cellular Longevity, vol. 2021,DOI: 10.1155/2021/3687700, 2021.

[85] J. Sharifi-Rad, C. Quispe, M. Butnariu, L. S. Rotariu, O. Sytar, S. Sestito, S. Rapposelli, M. Akram, M. Iqbal, A. Krishna, N. V. A. Kumar, S. S. Braga, S. M. Cardoso, K. Jafernik, H. Ekiert, N. Cruz-Martins, A. Szopa, M. Villagran, L. Mardones, M. Martorell, A. O. Docea, D. Calina, "Chitosan nanoparticles as a promising tool in nanomedicine with particular emphasis on oncological treatment," Cancer Cell International, vol. 21 no. 1,DOI: 10.1186/s12935-021-02025-4, 2021.

[86] B. Mansoori, A. Mohammadi, S. Hashemzadeh, S. Shirjang, A. Baradaran, M. Asadi, M. A. Doustvandi, B. Baradaran, "Urtica dioica extract suppresses miR-21 and metastasis-related genes in breast cancer," Biomedicine & Pharmacotherapy, vol. 93, pp. 95-102, DOI: 10.1016/j.biopha.2017.06.021, 2017.

[87] S. Rizk, N. Al Bast, M. H. Hodroj, J. Borjac, "Aqueous urtica dioica leaves extract inhibits proliferation of acute myeloid leukemia cells in vitro," Clinical Lymphoma Myeloma and Leukemia, vol. 17, pp. S279-S280, DOI: 10.1016/j.clml.2017.07.060, 2017.

[88] S. Fattahi, A. M. Ardekani, E. Zabihi, Z. Abedian, A. Mostafazadeh, R. Pourbagher, H. Akhavan-Niaki, "Antioxidant and apoptotic effects of an aqueous extract of Urtica dioica on the MCF-7 human breast cancer cell line," Asian Pacific Journal of Cancer Prevention, vol. 14 no. 9, pp. 5317-5323, DOI: 10.7314/apjcp.2013.14.9.5317, 2013.

[89] A. R. Carvalho, G. Costa, A. Figueirinha, J. Liberal, J. A. V. Prior, M. C. Lopes, M. T. Cruz, M. T. Batista, "Urtica spp: phenolic composition, safety, antioxidant and anti-inflammatory activities," Food Research International, vol. 99 no. 1, pp. 485-494, DOI: 10.1016/j.foodres.2017.06.008, 2017.

[90] A. O. Docea, D Calina, A. M Buga, O Zlatian, M. M. B Paoliello, G. D Mogosanu, C. T Streba, E. L Popescu, A. E Stoica, A. C Bîrcă, B. Ș Vasile, A. M Grumezescu, L Mogoanta, "The effect of silver nanoparticles on antioxidant/pro-oxidant balance in a murine model," International Journal of Molecular Sciences, vol. 21 no. 4,DOI: 10.3390/ijms21041233, 2020.

[91] E. A. Guzmán Hernández, "Renoprotective and hepatoprotective effects of hippocratea excelsa on metabolic syndrome in fructose-fed rats," Farmacia, vol. 68 no. 6, pp. 1106-1119, DOI: 10.31925/farmacia.2020.6.19, 2020.

[92] C. Bourgeois, É. A. Leclerc, C. Corbin, J. Doussot, V. Serrano, J.-R. Vanier, J.-M. Seigneuret, D. Auguin, C. Pichon, É. Lainé, C. Hano, "Nettle ( Urtica dioica L.) as a source of antioxidant and anti-aging phytochemicals for cosmetic applications," Comptes Rendus Chimie, vol. 19 no. 9, pp. 1090-1100, DOI: 10.1016/j.crci.2016.03.019, 2016.

[93] A. Basso, C. Marrassini, C. Anesini, S. Gorzalczany, "Acute hypotensive, diuretic and antioxidant activities induced by urtica circularis," European Journal of Medicinal Plants, vol. 14 no. 2,DOI: 10.9734/ejmp/2016/25661, 2016.

[94] K. Ghaima, N. M. Hashim, S. A. Ali, "Antibacterial and antioxidant activities of ethyl acetate extract of nettle ( Urtica dioica ) and dandelion (Taraxacum officinale)," Journal of Applied Pharmaceutical Science, vol. 3, pp. 96-99, 2013.

[95] M. Mzid, S. Ben Khedir, S. Bardaa, Z. Sahnoun, T. Rebai, "Chemical composition, phytochemical constituents, antioxidant and anti-inflammatory activities of Urtica urens L. leaves," Archives of Physiology and Biochemistry, vol. 123 no. 2, pp. 93-104, DOI: 10.1080/13813455.2016.1255899, 2017.

[96] S. Pandey, S. P. Sah, M. L. Sah, D. Mishra, "An antioxidant potential of hydromethanolic extract of urtica parviflora roxb," Journal of Basic and Clinical Pharmacy, vol. 1 no. 3, pp. 191-195, 2010.

[97] C. Scheau, C. Caruntu, I. A. Badarau, A. E. Scheau, A. O. Docea, D. Calina, A. Caruntu, "Cannabinoids and inflammations of the gut-lung-skin barrier," Journal of Personalized Medicine, vol. 11 no. 6,DOI: 10.3390/jpm11060494, 2021.

[98] M. El Haouari, M. Bnouham, M. Bendahou, M. Aziz, A. Ziyyat, A. Legssyer, H. Mekhfi, "Inhibition of rat platelet aggregation by Urtica dioica leaves extracts," Phytotherapy Research, vol. 20 no. 7, pp. 568-572, DOI: 10.1002/ptr.1906, 2006.

[99] M. Sifaki, D. Calina, A. O. Docea, S. Tsioumas, M. S. Katsarou, S. Papadogiorgaki, P. Fragkiadaki, D. E. Branisteanu, K. Kouskoukis, J. Tsiaoussis, D. A. Spandidos, "A novel approach regarding the anti-aging of facial skin through collagen reorganization," Experimental and Therapeutic Medicine, vol. 19 no. 1, pp. 717-721, DOI: 10.3892/etm.2019.8254, 2020.

[100] I. Turel, O. Yilmaz, E. Ayaz, G. Oto, U. Mercan, "Anthelmintic activity of Urtica dioica L. in mice naturally infected with aspiculuris tetraptera," Journal of Animal and Veterinary Advances, vol. 1 no. 12, pp. 1628-1630, 2008.

[101] A. M. Iordache, A. M. Buga, D Albulescu, R. C. Vasile, R. Mitrut, G. Georgiadis, I. E. Zisis, C. Mamoulakis, A. Tsatsakis, A. O. Docea, D. Calina, "Phosphodiesterase-5 inhibitors ameliorate structural kidney damage in a rat model of contrast-induced nephropathy," Food and Chemical Toxicology, vol. 143,DOI: 10.1016/j.fct.2020.111535, 2020.

[102] A. M. Kamal, "Double therapy with pegylated interferon and ribavirin for chronic hepatitis c. a pharmacogenetic guide for predicting adverse eventS," Farmacia, vol. 65 no. 6, pp. 877-884, 2017.

[103] M. T. Islam, C. Quispe, D. M. El-Kersh, M. Chandra Shill, K. Bhardwaj, P. Bhardwaj, J. Sharifi-Rad, M. Martorell, R. Hossain, A. Al-Harrasi, A. Al-Rawahi, M. Butnariu, L. S. Rotariu, H. A. Rasul Suleria, Y. Taheri, A. O. Docea, D. Calina, W. C. Cho, "A literature-based update on benincasa hispida (thunb.) cogn: traditional uses, nutraceutical, and phytopharmacological profiles," Oxidative Medicine and Cellular Longevity, vol. 2021,DOI: 10.1155/2021/6349041, 2021.

[104] G. Avci, E. Kupeli, A. Eryavuz, E. Yesilada, I. Kucukkurt, "Antihypercholesterolaemic and antioxidant activity assessment of some plants used as remedy in Turkish folk medicine," Journal of Ethnopharmacology, vol. 107 no. 3, pp. 418-423, DOI: 10.1016/j.jep.2006.03.032, 2006.

[105] M. Nassiri-Asl, F. Zamansoltani, E. Abbasi, M.-M. Daneshi, A.-A. Zangivand, "Effects of Urtica dioica extract on lipid profile in hypercholesterolemic rats," Journal of Chinese Integrative Medicine, vol. 7 no. 5, pp. 428-433, DOI: 10.3736/jcim20090506, 2009.

[106] N. R. Barman, S. Nandy, R. Datta, P. K. Kar, "Cardioprotective effect of ethanolic extract of Urtica parviflora roxb. against isoproterenol induced myocardial infarction in rats," Indian Journal of Pharmacology, vol. 45 no. 5, pp. 513-516, DOI: 10.4103/0253-7613.117782, 2013.

[107] A. Legssyer, A. Ziyyat, H. Mekhfi, M. Bnouham, A. Tahri, M. Serhrouchni, J. Hoerter, R. Fischmeister, "Cardiovascular effects of Urtica dioica L. in isolated rat heart and aorta," Phytotherapy Research, vol. 16 no. 6, pp. 503-507, DOI: 10.1002/ptr.1087, 2002.

[108] D. Shackebaei, A. Godini, M. Abolghazi, M. B. Majnouni, M. Hesari, "Protection of ischemic and reperfused rat heart by aqueous extract of urtica dioica," Iranian Cardiovascular Research Journal, vol. 4, pp. 107-111, 2010.

[109] G. A. Soliman, "The potential cardioprotective effect of matricaria chamomilla extract against diabetes-induced oxidative stress in rats," Farmacia, vol. 68 no. 2, pp. 269-279, DOI: 10.31925/farmacia.2020.2.12, 2020.

[110] A. Ahangarpour, M. Mohammadian, M. Dianat, "Antidiabetic effect of hydroalcholic urticadioica leaf extract in male rats with fructose-induced insulin resistance," Iranian Journal of Medical Sciences, vol. 37 no. 3, pp. 181-186, 2012.

[111] G. Kavalali, H Tuncel, S Göksel, H. H Hatemi, "Hypoglycemic activity of Urtica pilulifera in streptozotocin-diabetic rats," Journal of Ethnopharmacology, vol. 84 no. 2-3, pp. 241-245, DOI: 10.1016/s0378-8741(02)00315-x, 2003.

[112] H. Zhang, "Analysis of the polysaccharides from Urtica angustifolia and their anti-fatigue activity," African Journal of Pharmacy and Pharmacology, vol. 7 no. 22, pp. 1438-1447, DOI: 10.5897/ajpp12.170, 2013.

[113] I. Gülçin, O. I. Küfrevioglu, M. Oktay, M. E. Büyükokuroglu, "Antioxidant, antimicrobial, antiulcer and analgesic activities of nettle ( Urtica dioica L.)," Journal of Ethnopharmacology, vol. 90 no. 2-3, pp. 205-215, DOI: 10.1016/j.jep.2003.09.028, 2004.

[114] N. Jaradat, "Standardization the crude extracts of all urtica plant species growing in Palestine for quality control of cosmeceutical and pharmaceutical Formulations," International Journal of Pharmaceutical and Clinical Research, vol. 7, pp. 368-373, 2015.

[115] W. Wang, X. G. Yan, L. X. Duan, Y. Zhou, L. Tang, Y. Q. Wang, B. M. Feng, "Two new secolignans from the roots of Urtica maire i Levl," Chinese Chemical Letters, vol. 19 no. 10, pp. 1212-1214, DOI: 10.1016/j.cclet.2008.06.049, 2008.

[116] R. W. Hartmann, M. Mark, F. Soldati, "Inhibition of 5 α -reductase and aromatase by PHL-00801 (Prostatonin), a combination of PY102 (Pygeum africanum) and UR102 ( Urtica dioica ) extracts," Phytomedicine, vol. 3 no. 2, pp. 121-128, DOI: 10.1016/s0944-7113(96)80025-0, 1996.

[117] V. Khare, P. Kushwaha, S. Verma, A. Gupta, S. Srivastava, A. Rawat, "Pharmacognostic evaluation and antioxidant activity of urtica dioica L," Chinese Medicine, vol. 03 no. 03, pp. 128-135, DOI: 10.4236/cm.2012.33021, 2012.

[118] S. Gorzalczany, C. Marrassini, J. Miño, C. Acevedo, G. Ferraro, "Antinociceptive activity of ethanolic extract and isolated compounds of Urtica circularis," Journal of Ethnopharmacology, vol. 134 no. 3, pp. 733-738, DOI: 10.1016/j.jep.2011.01.025, 2011.

[119] C. Marrassini, C. Acevedo, J. Miño, G. Ferraro, S. Gorzalczany, "Evaluation of antinociceptive, antinflammatory activities and phytochemical analysis of aerial parts of Urtica urens L," Phytotherapy Research, vol. 24 no. 12, pp. 1807-1812, DOI: 10.1002/ptr.3188, 2010.

[120] Z. Doukkali, K. Taghzouti, E. H. Bouidida, M. Nadjmouddine, Y. Cherrah, K. Alaoui, "Evaluation of anxiolytic activity of methanolic extract of Urtica urens in a mice model," Behavioral and Brain Functions, vol. 11 no. 1,DOI: 10.1186/s12993-015-0063-y, 2015.

[121] Z. Yongna, R. Wantana, B. Pisit, L. Zhongkun, Z. Rongping, "Analgesic and antipyretic activities of the aqueous extract of Urtica macrorrhiza in experimental animals," Fitoterapia, vol. 76 no. 1, pp. 91-95, DOI: 10.1016/j.fitote.2004.10.018, 2005.

[122] C. Marrassini, R. Davicino, C. Acevedo, C. Anesini, S. Gorzalczany, G. Ferraro, "Vicenin-2, a potential anti-inflammatory constituent of Urtica circularis," Journal of Natural Products, vol. 74 no. 6, pp. 1503-1507, DOI: 10.1021/np100937e, 2011.

[123] K. Riehemann, B. Behnke, K. Schulze-Osthoff, "Plant extracts from stinging nettle ( Urtica dioica ), an antirheumatic remedy, inhibit the proinflammatory transcription factor NF- κ B," FEBS Letters, vol. 442 no. 1, pp. 89-94, DOI: 10.1016/s0014-5793(98)01622-6, 1999.

[124] M. Xiang, S. Zhang, J. Lu, L. Li, W. Hou, M. Xie, Y. Zeng, "Antilithic effects of extracts from Urtica dentata hand on calcium oxalate urinary stones in rats," Journal of Huazhong University of Science and Technology [Medical Sciences], vol. 31 no. 5, pp. 673-677, DOI: 10.1007/s11596-011-0580-3, 2011.

[125] M Bnouham, "Antihyperglycemic activity of the aqueous extract of Urtica dioica," Fitoterapia, vol. 74 no. 7-8, pp. 677-681, DOI: 10.1016/s0367-326x(03)00182-5, 2003.

[126] B. Tan, J. Vanitha, "Immunomodulatory and antimicrobial effects of some traditional Chinese medicinal herbs: a review," Current Medicinal Chemistry, vol. 11 no. 11, pp. 1423-1430, DOI: 10.2174/0929867043365161, 2004.

[127] Z. Biró-Sándor, "Assessment report on Urtica dioica L., Urtica urens L., their hybrids or their mixtures, radix," 2012. Report

[128] Chinese Rheumatism Data Center, Chinese Systemic Lupus Erythematosus Treatment and Research Group, "Recommendation for the prevention and treatment of non-steroidal anti-inflammatory drug-induced gastrointestinal ulcers and its complications," Zhonghua Nei Ke Za Zhi, vol. 56 no. 1, pp. 81-85, 2017.

[129] S. Chrubasik, A. Schmidt, H. Junck, M. Pfisterer, "Wirksamkeit und wirtschaftlichkeit von teufelskrallenwurzelextrakt bei rückenschmerzen: erste ergebnisse einer therapeutischen kohortenstudie," Complementary Medicine Research, vol. 4 no. 6, pp. 332-336, DOI: 10.1159/000210360, 1997.

[130] A. Tahri, S. Yamani, A. Legssyer, M. Aziz, H. Mekhfi, M. Bnouham, A. Ziyyat, "Acute diuretic, natriuretic and hypotensive effects of a continuous perfusion of aqueous extract of Urtica dioica in the rat," Journal of Ethnopharmacology, vol. 73 no. 1-2, pp. 95-100, DOI: 10.1016/s0378-8741(00)00270-1, 2000.

[131] A. Kalia, B. Joshi, M. Mukhija, "Pharmacognostical review of Urtica dioica L," International Journal of Green Pharmacy, vol. 8 no. 4, pp. 201-209, DOI: 10.4103/0973-8258.142669, 2014.

[132] P. Mittman, "Randomized, double-blind study of freeze-dried Urtica dioica in the treatment of allergic rhinitis," Planta Medica, vol. 56 no. 1, pp. 44-47, DOI: 10.1055/s-2006-960881, 1990.

[133] A. Amiri Behzadi, H. Kalalian-Moghaddam, A. H. Ahmadi, "Effects of Urtica dioica supplementation on blood lipids, hepatic enzymes and nitric oxide levels in type 2 diabetic patients: a double blind, randomized clinical trial," Avicenna Journal of Phytomedicine, vol. 6 no. 6, pp. 686-695, 2016.

[134] B. Sandor, "Assessment report on urttica dioica L., and urtica wens L., herba," 2008. Report

[135] B. Farzami, D. Ahmadvand, S. Vardasbi, F. J. Majin, S. Khaghani, "Induction of insulin secretion by a component of Urtica dioica leave extract in perifused islets of langerhans and its in vivo effects in normal and streptozotocin diabetic rats," Journal of Ethnopharmacology, vol. 89 no. 1, pp. 47-53, DOI: 10.1016/s0378-8741(03)00220-4, 2003.

[136] B. E. Anderson, C. J. Miller, D. R. Adams, "Stinging nettle dermatitis," American Journal of Contact Dermatitis: Official Journal of the American Contact Dermatitis Society, vol. 14 no. 1, pp. 44-46, DOI: 10.2310/6620.2003.38719, 2003.

[137] F. Oliver, E. U. Amon, A. Breathnach, D. M. Francis, P. Sarathchandra, A. Kobza Black, M. W. Greaves, "Contact urticaria due to the common stinging nettle ( Urtica dioica )-histological, ultrastructural and pharmacological studies," Clinical and Experimental Dermatology, vol. 16 no. 1,DOI: 10.1111/j.1365-2230.1991.tb00282.x, 1991.

[138] K. Kőszegi, J. Kocsis, G. Vatai, E. Bekassy-Molnar, "Antimicrobial effects of the stinging nettle (urtica dioica L.)," Analecta Technica Szegedinensia, vol. 11 no. 2, pp. 10-15, 2017.

[139] N. Deye, F. Vincent, P. Michel, S. Ehrmann, D. da Silva, M. Piagnerelli, A. Kimmoun, O. Hamzaoui, J.-C. Lacherade, B. de Jonghe, F. Brouard, C. Audoin, X. Monnet, P.-F. Laterre, "Changes in cardiac arrest patients’ temperature management after the 2013 “TTM” trial: results from an international survey," Annals of Intensive Care, vol. 6 no. 1,DOI: 10.1186/s13613-015-0104-6, 2016.

[140] G. M. Kavalali, Urtica: Therapeutic and Nutritional Aspects of Stinging Nettles, 2003.

[141] Drugs and Lactation Database (LactMed), Stinging Nettle, 2021.

[142] T. Teucher, B. Obertreis, T. Ruttkowski, H. Schmitz, "Cytokine secretion in whole blood of healthy subjects following oral administration of Urtica dioica L. plant extract," Arzneimittelforschung, vol. 46 no. 9, pp. 906-910, 1996.